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Abstract
Background: Nitrotoluenes are widely used chemical manufacturing and munitions applications. This group of chemicals
has been shown to cause a range of effects from anemia and hypercholesterolemia to testicular atrophy. We have examined
the molecular and functional effects of five different, but structurally related, nitrotoluenes on using an integrative systems
biology approach to gain insight into common and disparate mechanisms underlying effects caused by these chemicals.
Methodology/Principal Findings: Sprague-Dawley female rats were exposed via gavage to one of five concentrations of
one of five nitrotoluenes [2,4,6-trinitrotoluene (TNT), 2-amino-4,6-dinitrotoluene (2ADNT) 4-amino-2,6-dinitrotoulene
(4ADNT), 2,4-dinitrotoluene (2,4DNT) and 2,6-dinitrotoluene (2,6DNT)] with necropsy and tissue collection at 24 or 48 h.
Gene expression profile results correlated well with clinical data and liver histopathology that lead to the concept that
hematotoxicity was followed by hepatotoxicity. Overall, 2,4DNT, 2,6DNT and TNT had stronger effects than 2ADNT and
4ADNT. Common functional terms, gene expression patterns, pathways and networks were regulated across all
nitrotoluenes. These pathways included NRF2-mediated oxidative stress response, aryl hydrocarbon receptor signaling, LPS/
IL-1 mediated inhibition of RXR function, xenobiotic metabolism signaling and metabolism of xenobiotics by cytochrome
P450. One biological process common to all compounds, lipid metabolism, was found to be impacted both at the
transcriptional and lipid production level.
Conclusions/Significance: A systems biology strategy was used to identify biochemical pathways affected by five
nitroaromatic compounds and to integrate data that tie biochemical alterations to pathological changes. An integrative
graphical network model was constructed by combining genomic, gene pathway, lipidomic, and physiological endpoint
results to better understand mechanisms of liver toxicity and physiological endpoints affected by these compounds.
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Introduction
Nitro-reduction of the munitions compound 2,4,6-trinitrotolu-
ene (TNT) during environmental degradation produces 2-amino-
4,6-dinitrotoluene (2A-4,6DNT or 2ADNT) and 4-amino-2,6
dinitrotoluene (and 4A-2,6DNT or 4ADNT). Other structurally
similar munitions compounds include the dinitrotoluenes, 2,4-
dinitrotoluene (2,4DNT) and its isomer 2,6-dinitrotoluene
(2,6DNT). This class of chemicals has been reported to
contaminate land, water and retired ammunitions plants as a
result of military activities and a series of manufacturing processes
[1–3]. The major biological effects of TNT subchronic and
chronic exposure are anemia (both aplastic and hemolytic),
methemaglobinemia, hypercholesterolemia, and testicular atrophy
with accompanying histological lesions [4]. DNT and ADNT
exposure have been reported to cause hepatomegaly and
splenomegaly in addition to cytotoxic and genotoxic effects [5–
8]. However, the mutagenicity of TNT is controversial [9]. TNT
has been shown to interact with hemoglobin to form adducts,
mainly 2ADNT and 4ADNT, while 2,4DNT and 2,6DNT have
been reported to produce 4-amino-2-nitrotoluene (4A2NT) and
2,4-toluenediamine (24TDA), and 2-amino-6-nitrotoluene
(2A6NT) and 26TDA, respectively [10,11].
Fathead minnow exhibited that lipid metabolism and oxygen
transport pathways were the primary mechanism for 2,4DNT
induced toxicity in fish [2]. The exposure of Eisenia fetida
modulated the expression of genes involved in multiple biological
processes including muscle contraction, neuronal signaling and
growth, ubiquitinylation, fibrinolysis and coagulation, iron and
calcium homeostasis, oxygen transport, and immunity [12].
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compounds are known, a systematic study using toxicogenomics
along with such responses is warranted in order to fully understand
the relative toxicity of these nitroaromatics in mammals. Moreover,
the underlying mechanisms of toxicity induced by these compounds
especially for acute exposures, are largely unknown, and little if any
toxicogenomics and systems biology studies have been conducted in
exposed mammals. An acute exposure is advantageous in that early
biomarkers and pathways may be identified to predict future
toxicity induced by these chemicals.
To facilitate study of mechanisms, we chose to profile and
integrate genomics, system biology and classical toxicological
endpoints from the same biological samples shortly after a single
exposure to one of five concentrations of one of the 5 nitrotoluene
compounds with sacrifice and tissue collection after 24 or
48 hours. Assessment included physiological endpoint measure-
ments and genomics of liver tissues using microarrays. Overall, we
found that the expression results correlated well with toxicological
and pathological results. Although each compound affected a
distinctive expression pattern, a common group of genes and
pathways were significantly affected by most of the compounds.
We demonstrate a network mode of action based on the gene
expression profiles, which could explain why the physiological
responses occurred after exposure to these compounds.
Results
Analytical chemistry
Blood from rats exposed to each of the five nitrotoluenes, TNT,
2ADNT, 4ADNT, 2,6DNT, and 2,4DNT, for either 24 or 48 h was
examined for the presence of parent compound and/or possible
nitrotoluene metabolites using HPLC. At 24 h, measurable concen-
trations of nitrotoluenes were found only in blood of the two highest
TNT dosed and 3 highest dosed 2ADNT dosed animals (File S1).
2ADNT was the only metabolite observed in blood of the two highest
dosed TNT treated animals 24 h after exposure. No measurable
a m o u n t so fa n yo ft h ef i v en i t r o t o l u e n ec o m p o u n d so rt h e i r
degradation products were found in blood 48 h after the exposure.
Liver tissue of exposed and control rats were examined for the
presence of parent chemicals and their metabolites 24 and 48 h
after exposure. In livers of exposed rats, only the parent
compounds TNT, 2ADNT, and 2,4DNT were detected at 24 h,
but only in one replicate (File S1). Metabolites of TNT were
observed in livers of 192 and 384 mg/kg TNT exposed rats at
24 h after exposure where 2,6-diamino-4-nitrotoluene and 2,4-
diamino-6-nitrotoluene were detected.
At lower doses of 96 and 48 mg/kg TNT-treatments, 2ADNT
was found in liver of one animal for each dose, while no 4ADNT
was observed. No measurable concentrations of the other four
nitrotoluene parent compounds were found in livers of animals
after 48 h (File S1). Further metabolic products such as
azoxytoluenes and benzylalcohols were not measured under the
protocol utilized.
Toxicity measurements
Although the upper limit of chemical dose ranges were designed
to be one-half the published acute oral LD50, lethality was
observed within the dose range used for the dinitrotoluenes. The
TNT dose was based on the publication of Reddy at al., [13]. The
doses of 2,4DNT and 2,6DNT were based on the publication of
Ellis et al.,[14]. The dose selection for 2ADNT and 4ADNT were
based on the report of Ellis et al., [15].
All treated rats expired at the high dose (398 mg/kg) of
2,6DNT. The high dose of 2,4DNT caused deaths of 2 of 5 and 1
of 5 rats at 24 and 48 h, respectively. Systemic toxicity was also
indicated for all compounds by decreases in body weight gain over
the 48 h observation period. Body weight gain for vehicle-treated
rats was 1761 g (mean6SEM, n=5) compared to a loss of 627g
for 199 mg/kg 2,6DNT and high dose (384 mg/kg) TNT. Weight
gains were reduced to between 1 to 4 g for rats treated with 50 and
99 mg/kg 2,6DNT, 398 mg/kg 2,4DNT and 192 mg/kg TNT
and to 529 g for 48 and 96 mg/kg TNT, 174 and 348 mg/kg
2ADNT, and 374 mg/kg 4ADNT. Body weight loss associated
with higher doses of TNT and dinitrotoluenes was possibly related
to reduced food consumption as indicated by a coincident decrease
in serum alkaline phosphatase (AlkP, Tables 1,2) [16].
Additional differences detected from the comprehensive serum
metabolic panel included effects on serum albumin, total protein,
glucose and Na (Tables 1,2). Serum albumin was the parameter
changed at the lowest level of exposure also known as lowest
observed effect level (LOEL). Serum albumin decreased at 48 h
after exposure with a LOEL of 99 mg/kg 2,4DNT and LOEL of
TNT at 192 mg/kg. Changes in total protein paralleled those of
albumin (data not shown). Glucose was elevated at 48 h with
2,4DNT (high dose) and reduced at 48 h with 4ADNT (LOEL
47 mg/kg). Serum sodium levels were decreased at 24 h after
2,6DNT (199 mg/kg) and 2ADNT (348 mg/kg) exposures and at
48 h after 2,4DNT (LOEL 198 mg/kg) and TNT (384 mg/kg)
exposures. No significant treatment-related changes were observed
for total bilirubin, creatinine or urea (data not shown).
Serum alanine aminotransferase (ALT) activity exhibited a
dose-dependent decrease to 33% of vehicle control at 24 h after
4ADNT exposure with doses greater than 5 mg/kg. This effect
was not sustained to 48 h post-exposure, but rather an increase
was observed for the 94 mg/kg group. A similar trend of lesser
magnitude occurred with serum aspartate aminotransferase (AST).
Small declines in serum transaminase activities are occasionally
observed with some chemicals often due to inhibition of enzymatic
utilization of cofactor pyridoxyl-59-phosphate; however, this effect
is thought to be of relatively minor toxicological significance [17].
One rat in each of the 50 and 99 mg/kg 2,6DNT groups (48 h)
had serum ALT values in excess of 3000 IU/ml that thus caused
their treatment means to exceed 7 times the control mean with
,200% coefficient of variation (Table 1). Histopathology verified
that these values truly reflected hepatotoxicity of sensitive rats
within their treatment groups (Figure 1A and 1B). Livers of these
rats contained congested sinusoids, some with sloughed hepatocyte
remnants (arrow, Figure 1A). Segmented neutrophils were
frequent, but confined to the sinusoids. Central veins and lining
endothelia appeared normal with unaffected proximal hepatocytes
in radiating cords. However, several cords become disorganized at
midzonal regions where erythrocytes appeared to infiltrate and
adjacent hepatocytes exhibited pyknotic nuclei (arrowhead,
Figure 1B) and microvesiculated cytoplasm (asterisks, Figure 1A).
In addition, apoptotic hepatocytes were evident (asterisk,
Figure 1B). Others have shown necrosis and hemorrhage in livers
of rats with 50% lethality at 24 h after 50 mg/kg 2,6DNT, i.p.,
while equivalent treatment with 2,4DNT was without effect [8].
In contrast, hepatocytes of rats treated with the higher dose of
2,6DNT whose serum ALT levels were equivalent to vehicle
controls appeared mostly undamaged (Figure 2B), however,
sinusoids were markedly congested. Occasional erythrocyte
infiltration between adjacent hepatocytes within a cord was noted
(arrow, Figure 2D), but without associated necrosis as seen in the
sensitive animals (arrowhead, Figure 1B). Enlarged nucleoli were
evident in several hepatocytes of treated rat liver in agreement
with ultrastructural changes after single dose dinitrotoluene
reported previously [18].
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Cytoplasmic amorphous inclusions were noted in hepatocytes of 3
livers and microvesicles in another of the 5 rats treated with 384 mg/kg
TNT (Figure 1C). Livers of 4 of 5 rats treated with high dose TNT had
r e g i o n sw h er es i n u s o i d sw er ec o n ge s t e d ,bu tl es sa r e aw a si nv o l v e dth a n
seen with dinitrotoluene-treated rats. Focal hemorrhages were seen in
the liver of one rat at 48 h after treatment with 94 mg/kg 4ADNT
(Figure 1D), while ballooning degeneration was common in livers from
other rats 48 h after 94 and 187 mg/kg 4ADNT (Figure 1E). No
pathological lesions were seen in livers of rats treated with 2ADNT.
Relative liver weights of rats treated with 4ADNT increased from
4.1260.11% to 4.8260.05%, 4.7760.05% and 4.7660.18%
Table 1. Clinical Chemistry Outcomes Affected by 2,4- and 2,6-DNT and TNT
a.
Dose Time Albumin ALT
b AST AlkP Glucose Na
mg/kg hr g/dL IU/L IU/L IU/L mg/dL mmol/L
24DNT
0 24 1.3860.04 132.262.9 237.2633.9 273.2629.5 226.6614.9 143.860.8
48 1.5860.02 104.666.6 311.8665.8 273.0621.4 260.8625.0 143.460.7
5 24 1.4260.04 128.863.7 363.8650.7 269.0620.2 255.4611.3 145.061.2
48 1.5660.02 95.065.0 275.2658.1 262.0615.5 241.4622.4 144.560.7
50 24 1.4260.04 139.4612.0 384.4687.9 310.6626.8 227.2614.3 143.660.7
48 1.5460.04 95.2611.1 316.46111.4 230.0621.0 219.468.8 144.460.8
99 24 1.3060.03 124.6615.3 506.06111.4 279.0636.2 234.8619.5 140.863.8
48 1.3860.05** 97.264.1 280.4641.0 224.6628.8 221.6612.3 143.260.9
198 24 1.3660.05 96.0621.5 392.4686.5 237.6615.6 225.4615.1 139.262.6
48 0.9060.06** 96.061.3 440.0635.4 112.5624.3** 393.5693.2 137.061.9**
398 24 1.5, 1.4 116, 60 514, 200 115, 95 184, 275 142, 139
48 0.7760.03** 132.3613.0 755.0662.6** 130.067.5** 686.7648.2** 127.762.5**
26DNT
0 24 1.4660.04 144.464.2 332.0632.3 277.4619.0 257.8612.7 145.260.5
48 1.5460.06 98.465.6 154.2612.2 250.265.1 221.369.4 144.062.0
5 24 1.5460.02 128.869.8 306.0647.3 318.8617.1 226.0621.2 147.861.0
48 1.6460.02 98.267.9 161.468.4 258.0612.9 255.062.0 147.061.0
25 24 1.5260.02 163.6616.8 567.46137.3 334.6622.1 214.2624.0 145.060.8
48 1.6260.03 95.465.0 267.2648.9 279.0627.4 211.668.6 146.460.4
50 24 1.5460.02 138.267.1 341.8636.7 312.6622.3 246.4613.2 145.460.8
48 1.4260.05 738.8±627.7 1529.0±1310.6 257.8615.9 224.0611.0 144.062.0
99 24 1.4660.05 174.8627.7 633.66164.7 241.6618.0 193.6611.1* 141.861.8
48 1.3060.14 743.0±622.3 1046.6±697.6 269.0629.4 186.0612.1 145.060.6
199 24 1.5460.04 150.0627.9 779.06176.2* 199.4627.8 293.4610.6 136.660.9**
48 1.0 208 234 128 nd nd
TNT
0 24 1.3860.02 140.4633.0 366.8652.6 294.2613.7 174.4638.5 151.666.6
48 1.5260.04 172.4624.1 463.36145.0 252.8636.9 222.0620.4 141.861.2
5 24 1.3460.02 105.068.5 309.6644.9 347.0613.9 217.269.3 146.260.4
48 1.5860.02 147.8640.0 267.5653.3 222.0627.5 246.6616.0 144.460.7
48 24 1.4060.05 81.666.5 329.8651.4 318.0610.2 209.269.5 145.460.9
48 1.6060.03 129.865.8 478.2690.6 247.2616.9 232.4619.3 143.061.1
96 24 1.3460.02 76.0615.9* 408.86108.6 284.2611.7 208.869.4 141.861.4
48 1.5060.03 125.0618.7 433.86103.6 190.6621.0 224.4614.9 144.661.2
192 24 1.4060.03 45.666.8** 251.2653.0 272.2628.0 260.2618.3 141.661.1
48 1.3660.05* 128.4653.0 475.26143.8 215.0620.1 239.4615.3 136.863.4
384 24 1.4260.04 42.465.8** 248.2648.8 224.4620.9* 228.4642.9 141.861.4
48 1.3360.02** 122.5655.3 354.9668.7 208.0613.2 211.8613.2 132.861.1**
aValues are means6SEM for n=5, except for 198 and 398 mg/kg 24DNT 48 h where n=3 and for 398 mg/kg 24DNT 24 h where individual values are shown. For
199 mg/kg 26DNT 48 h values are from pooled sample for 3 rats. Means that differed from concurrent vehicle controls (0 mg/kg) are indicated by * or ** for p,0.05 or
0.01, respectively.
bAbbreviations. AlkP=alkaline phosphatase, ALT and AST=alanine and aspartate aminotransferase, resp., nd=not determined.
doi:10.1371/journal.pone.0014662.t001
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374 mg/kg, respectively. TNT at 384 mg/kg was associated with
an increased liver weight of 4.9060.23% relative to 4.0360.17%
for controls. The 99 mg/kg 2,4DNT group also had an elevated
relativeliverweightof4.5960.09%comparedtoconcurrentvehicle
control (3.8560.08%), but higher doses (199 mg/kg=4.0660.25;
389 mg/kg=4.2960.18) were unaffected. Liver weights of rats
treated with 2,6DNT and 2ADNT were unchanged from vehicle
controls at 48 h post-treatment.
The most notable finding from the hematology panel was an
elevation of several related parameters indicating erythrocytosis
associated with the dinitrotoluenes (Tables 3, 4). Erythrocyte count
was elevated at 99 mg/kg at 24 h post-exposure and at 199 mg/
kg and above at 48 h for both compounds. Increases in
hemoglobin concentration and hematocrit paralleled that of
erythrocyte count. For all parameters, the magnitude of change
was greater for 2,6DNT than 2,4DNT. At 48 h after 199 mg/kg
2,6DNT, hemoglobin and hematocrit reached high values of
20 g/dL and 61% respectively. 2,6DNT, but not 2,4DNT,
produced an increase in blood reticulocytes and was associated
with mature erythrocytes with Heinz bodies and ‘‘bite cells’’
(Figure 3). TNT-treated rats exhibited increases in erythrocyte
count and hemoglobin 24 h post-exposure at 192 and 384 mg/kg,
respectively, but these effects were not sustained to 48 h nor of the
magnitude seen with 2,6DNT. In contrast, blood erythrocyte
parameters showed downward trends with 4ADNT as evidenced
by ,10% declines in hemoglobin and hematocrit at 48 h after
treatment with 94 mg/kg and above (Tables 3, 4). Treatment with
2ADNT was without effect.
Marked elevation of blood granulocytes were noted at 48 h after
high dose 2,4DNT and TNT and 199 mg/kg 2,6DNT (3). Earlier
elevations occurred with 2,4DNT at doses of 99 mg/kg and above
and with 384 mg/kg TNT. Granulocytosis at 24 h for TNT and at
48 h for 2,4DNT tended to parallel a decrease in lymphocytes as
often occurs with corticosteroid-mediated stress [17]. In contrast,
leukocyte counts of rats treated with the amino-dinitrotoluenes were
unaffected by treatment at either time point (Table 4).
Dose responsive differentially expressed gene numbers
in liver affected by nitrotoluenes
A strong dose responsive change in the total number of
differentially expressed genes was observed at both time points for
all compounds (Figure 4). The dose responsive change suggests
that the doses are in an appropriate linear range for the
microarray experiment. The number of statistically regulated
transcripts was consistently larger at 24 h than 48 h for all
Table 2. Clinical Chemistry Outcomes Affected by 2ADNT and 4ADNT
a.
Dose Time Albumin ALT
b AST AlkP Glucose Na
mg/kg hr g/dL IU/L IU/L IU/L mg/dL mmol/L
2ADNT
0 24 1.4260.04 116.864.2 314.7672.0 359.6620.4 224.8615.7 143.660.8
48 1.6060.04 138.067.1 225.6632.6 283.8643.7 253.669.4 141.461.1
4 24 1.3660.02 151.2641.1 403.86112.1 328.4611.0 238.2612.9 141.661.4
48 1.5260.04 143.4621.0 364.86105.8 204.6629.0 200.866.6* 141.661.7
44 24 1.3660.04 92.062.5 211.6611.1 387.8630.9 228.263.4 142.860.4
48 1.5860.07 174.6635.0 477.46107.7 203.4619.4 217.0615.8 139.862.1
87 24 1.3860.04 91.666.1 341.8658.0 338.4628.9 221.065.5 141.860.4
48 1.5660.05 99.464.4 128.8610.1 205.8627.7 212.268.4 144.660.4
174 24 1.3460.02 91.662.8 316.2653.4 249.0624.7 207.0610.4 142.060.8
48 1.6060.03 109.667.1 166.0613.5 230.2611.3 226.4616.9 143.660.4
348 24 1.3460.05 89.469.6 352.8644.1 388.0613.2 241.6614.8 139.860.9*
48 1.5260.04 127.4620.4 268.46124.5 212.0619.4 213.0614.9 141.661.3
4ADNT
0 24 1.3060.01 143.266.6 417.4637.8 342.8633.3 284.4611.8 143.660.8
48 1.4260.04 195.2618.9 630.8676.4 216.8623.2 232.4611.0 136.260.5
5 24 1.3460.02 122.666.1 364.4665.7 329.0619.9 235.266.8 144.860.4
48 1.4260.02 202.4643.5 489.86161.9 238.0621.1 253.4616.0 136.661.4
47 24 1.3260.04 86.664.7** 201.0627.7** 339.6625.5 225.0611.9** 145.060.5
48 1.5060.04 254.6649.0 733.86150.0 307.0620.7 243.6616.0 134.461.2
94 24 1.3260.04 66.663.4** 182.2614.6** 342.6619.7 226.0613.3** 144.660.5
48 1.4660.02 727.26253.5* 1911.86421.0* 280.0633.7 324.4632.9** 126.262.6**
187 24 1.3260.02 56.466.6** 243.6637.8* 323.2635.2 202.865.3** 143.460.9
48 1.4260.06 405.0657.4 1505.86228.2 205.8611.9 275.6613.9 130.461.8
374 24 1.4260.02* 48.264.9** 283.4626.7 317.4634.4 230.668.7** 142.261.2
48 1.4060.3 271.0695.0 1247.46305.4 377.86124.6 260.8616.4 131.861.7
aValues are means6SEM for n=5. Means that differed from concurrent vehicle controls (0mg/kg) are indicated by * or ** for p,0.05 or 0.01, respectively.
bAbbreviations. AlkP=alkaline phosphatase, ALT and AST=alanine and aspartate aminotransferase, resp.
doi:10.1371/journal.pone.0014662.t002
Mechanisms of Nitrotoluenes
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e14662compounds except TNT. TNT was reversed in comparison to the
other 4 compounds in that it produced a higher number of altered
transcripts at 48 h. In light of the chemistry data, metabolism of
TNT into 2,6DNT and 2,4DNT in liver may cause a lag in a
decrease of observed impacts upon gene expression.
While the dose responsive pattern of the number of gene expression
was similar for the compounds examined (Figure 4), there was a large
difference in the total number affected by the chemicals (Figure 5). We
observed a remarkable difference in the number of altered genes for
both time points together (24 h+48 h) induced by the 5 compounds
(Figure 5). 2,4 DNT displayed the highest changed number (close to
6000) at 24 h+48 h,followed by 2,6 DNT (nearly 5000), 4ADNT (over
1000), TNT (nearly 700) and 2ADNT (110) (Tables S1, S2, S3, S4, S5,
S6, S7, S8, S9, S10). The identification of very few differentially
expressed transcripts by 2ADNT relative to the other nitrotoluenes is
consistent with observed clinical effects suggesting that reduction of the
nitroso group to an amino group at ring position C-2 dramatically
reduces the biological effects of nitrotoluenes.
Next, we determined the amount of up-regulated or down-
regulated transcript numbers for the compounds. To do that, we
compared treated and control samples at 24 h or 48 h or both
time points together for each compound. Based on significantly
regulated transcripts, if the averaged normalized intensity of a
gene was higher in the treated group than the control group, we
considered the gene relatively up-regulated; and if lower, down-
regulated. According to this criterion, we found another common
phenomenon: there were much more up-regulated transcripts
than down-regulated transcripts at 24h and both time points
together (24 h+48 h) (Figure 5) for 2,4DNT, 2,6DNT, 2ADNT,
4ADNT and TNT. Interestingly, at 48 h, there were far more
down-regulated transcripts than up-regulated transcripts for the 4
compounds 2,4DNT, 2,6DNT, 2ADNT, 4ADNT. TNT showed a
reverse trend once again in that it induced more up-regulated
transcripts at 48 h than down-regulated ones. Our results indicate
that not only was a trend conserved for the dose responsive effects,
but also a time –responsive up and down-regulated trend among
these compounds was conserved, implicating that a common
underlying mechanism may be shared by these compounds.
Comparison of general gene expression profiles induced
by the 5 compounds
The overall gene expression profiles induced by the 5 chemicals with
various doses and different times were compared by two-way
hierarchical clustering of averageso fr e p l i c a t e sw i t h i ne a c ho ft h e4 0
conditions (Figure 6). The dendrogram was clearly divided into 3
groups. Eight conditions formed the first group containing 3 conditions
from 2,4DNT, all 4 conditions from 2,6DNT at 24 h, and one from
2ADNT at 48 h. The second group included 22 conditions.
Figure 1. Pathology of livers from rats treated 48 h earlier with 50 mg/kg 2,6DNT (A,B) or 384 mg/kg TNT (C). Photomicrographs are
from 5 mm sections stained with hematoxylin and eosin. Livers from one of 5 rats treated with 50 mg/kg 2,6DNT exhibited sloughing of hepatocyte
remnants into congested sinusoids (A, arrow) and microvesiculated hepatocytes (A, *). A necrotic hepatocyte with pyknotic nucleus displaced from
the liver cord by infiltrating erythrocytes is shown in B (arrow). Numerous apoptotic cells (B, *) were also seen. Amorphous vacuoles occupying a
considerable portion of hepatocyte cytoplasms were numerous in livers of 3 of 5 rats treated with 384 mg/kg TNT (C, arrows). One rat treated with
94 mg/kg 4ADNT had focal hemorrhagic areas in the liver (D, arrows), while livers of other rats treated with 94 and 197 mg/kg 4ADNT exhibited
ballooning degeneration (E).
doi:10.1371/journal.pone.0014662.g001
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from 2ADNT, 4ADNT and TNT except two conditions from
2,4DNT, 48 h. The third group contained 10 conditions in which two
distinctive subgroups were formed. One subgroup contained 3
conditions that were from 2ADNT at 48 h, while the other subgroups
included conditions from 2,4DNT at 48 h and 2,6DNT at 48 h.
Experimental conditions with the same chemical dose and time were
likelyto clustertogether. Conditions within the same dose and the same
compound from different time points (24 h or 48 h) seldom clustered
together in a subgroup indicating that the time effect is much stronger
than the dose effect for all the compounds.
FromFigure6,mostofthegeneexpressionprofilesof2,4DNTand
2,6DNT clustered together and most of the 2ADNT, 4ADNT and
TNT induced gene expression profiles grouped together. From
supplementary Figure 1A (File S1), we noticed that gene expression
profiles of 2,4DNT and 2,6DNT clustered together and 2ADNT,
4ADNT and TNT induced gene expression profiles grouped
together. We further made averaged conditions based on compound
treatments and ignored dose and time effects. A simple condition tree
using the same flagged transcripts is shown in supplementary
Figure 1B. 2,4DNT and 2,6DNT formed in one separate group,
2ADNT, 4ADNT and TNT were located in the other group in
which 4ADNT and TNT were clustered together. Since 2ADNT
and 4ADNT are metabolites of TNT, it is easy to understand that the
3 compounds form in a group. The expected results provide proof
that this high-throughput experiment is reliable.
Common gene expression patterns of significantly
differentially expressed genes due to nitrotoluene
exposure
We also performed a hierarchical clustering per treatment.
Because the two very strong gene regulators, 2,4DNT and
2,6DNT have over 2000 genes that were affected, in order to
identify most significantly regulated genes, a more stringent false
discovery rate (FDR) with adjusted p-value less than 0.002 was
applied resulting in 1418 and 1241 significantly differentially
expressed transcripts for 2,4DNT and 2,6DNT, respectively. For
the other three compounds, no more stringent FDR was applied
because their changed gene numbers were much less than 2000.
One-way hierarchical clustering was performed across various
doses and times per chemical. Interestingly, the 5 compounds
share similar gene expression patterns (Figure 7). The genes were
primarily divided into two distinctive expression patterns: early up-
regulated (24 h) and early down-regulated (24 h). Other common
patterns shared by the 5 compounds include a clear dose response
for both up-regulated and down-regulated transcripts at 24 h. We
also noticed that there were more up-regulated than down-
regulated genes at 24 h for all the compounds which is consistent
with Figure 5. For all the compounds but 2ADNT, transcripts
generally up-regulated at 24 h were also up-regulated at 48 h as
well. The common gene expression patterns shared by the
compounds imply that these compounds may share some common
mechanisms.
Figure 2. Representative photomicrographs of livers from rats treated 48 h earlier with vehicle (5% DMSO in corn oil, A and C) or
199 mg/kg 2,6DNT (B and D). Photomicrographs are from 5 mm sections stained with hematoxylin and eosin. Extensive sinusoidal congestion of
2,6DNT-treated rats is shown in panel B and compared to unaffected liver of vehicle treated controls in panel A. Higher power magnification
illustrates infiltration of hepatocyte cords by erythrocytes (D, arrows) and microvesiculation (D, *) seen in livers of 2,6DNT-treated rats. Unaffected liver
of vehicle-treated controls at high magnification is shown in panel C.
doi:10.1371/journal.pone.0014662.g002
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among the 5 compounds
To gain insight into the functional categories of these
significantly changed genes, we performed gene ontology (GO)
analyses based on biological processes. Early up-regulated and
early down-regulated gene groups for each compound across all
doses (Figure 7) underwent GO analyses separately. We first
examined the similarity of functional terms from the up-regulated
gene groups between compounds (Table 5). The greatest overlap
occurred between 2,4DNT and 2,6DNT. 4ADNT also had a
relatively high similarity of functional terms with 2,4DNT and
2,6DNT (Table 5). These results are consistent with the
comparison of general gene expression profiles (Figure 6 and File
S1). Consistent with observations of little effect on biological
Table 3. Hematology Outcomes Affected by 2,4- and 2,6-DNT and TNT
a.
Dose Time Granulocytes Lymphocytes Erythrocytes HbG
b HCt RDW Retic
mg/kg hr 10
6/mL 10
6/mL 10
9/mL g/dL % % %
2,4DNT
0 24 0.2360.15 2.9460.63 7.2060.14 13.760.2 41.360.8 10.960.1 3.060.1
48 0.5260.13 4.2160.36 6.6560.09 13.060.1 40.360.3 11.260.1
5 24 0.5260.14 3.2760.69 7.3760.18 13.960.2 42.260.5 11.060.1 2.560.1
48 0.7760.25 3.1160.66 6.8360.07 12.860.3 40.160.3 10.760.3
50 24 0.5160.21 3.1260.46 7.6360.11 14.360.3 44.060.6* 11.060.1 2.060.2
48 0.9860.20 4.3161.22 6.9360.08 13.360.1 41.660.4 11.160.1
99 24 1.5060.15** 4.8460.60 7.9660.08** 14.360.2 44.660.5** 11.260.2 2.360.2
48 1.0660.15 2.5460.71 6.6360.06 12.460.3 39.860.5 10.960.1
198 24 1.0260.25* 3.0960.64 7.6560.04* 14.260.1 42.960.4 10.960.1 2.560.4
48 4.7360.60 3.0160.22 8.9660.43** 17.060.9** 53.662.0** 11.560.1
398 24 3.6, 2.4 1.8, 3.5 8.53, 6.04 15.3, 12.7 45.0, 39.3 10.6, 10.6 3.3, 3.3
48 8.3862.94** 0.9760.23* 8.6960.16** 16.560.2** 51.860.9** 12.060.7
2,6DNT
0 24 0.3660.22 6.1661.23 7.3960.18 13.960.3 43.460.9 11.360.1 3.460.2
48 0.6860.18 3.8660.30 7.1160.11 14.160.1 43.160.3 11.260.1
5 24 0.2960.13 5.1260.85 7.5760.20 14.160.3 44.861.1 11.060.2 3.060.2
48 0.5860.21 3.5060.36 7.3260.13 14.160.2 43.360.7 11.360.2
25 24 0.2060.08 5.4260.82 7.9460.29 15.160.6 46.761.8* 11.060.1 3.160.2
48 0.4960.09 3.5660.52 6.9660.12 13.660.1 41.260.4 10.860.1
50 24 0.7660.08 5.2560.90 8.0360.18 14.660.2 46.161.1 11.160.1 3.760.1
48 1.4560.35 4.9560.25 7.4760.26 14.460.5 43.661.5 11.160.2
99 24 0.8360.14 3.9660.37 8.4360.17** 15.360.3* 48.861.1* 11.060.1 4.160.2*
48 1.3660.66 4.8660.50 7.5860.21 14.760.4 44.661.2 11.160.1
199 24 0.7860.22 1.5260.39** 8.0260.12 14.660.2 45.760.8 11.060.2 4.960.1**
48 7.5860.99** 5.4662.05 11.4360.94** 20.461.3** 60.664.9** 12.560.4**
TNT
0 24 0.3360.17 6.2260.79 7.6260.14 14.560.2 44.960.8 10.960.2
48 1.0660.18 4.0960.26 7.3660.38 13.660.3 42.661.2 10.960.4
5 24 0.4360.11 5.3360.73 7.0860.23 13.660.3 41.661.4 10.660.2
48 0.9760.23 4.5560.46 7.7060.41 13.860.3 45.062.7 11.160.3
48 24 0.2360.09 5.9360.82 7.8560.25 14.460.3 46.361.4 10.860.2
48 1.0060.26 4.7960.92 7.1260.07 13.760.1 41.660.2 10.660.1
96 24 0.6060.49 4.7660.37 7.7960.11 14.760.2 45.660.7 11.060.2
48 0.9960.19 4.9560.36 7.5360.51 13.760.4 43.163.0 11.260.2
192 24 2.1661.02 2.9560.46** 8.6160.41* 15.160.3 48.862.3 10.960.2
48 1.4260.21 4.0160.46 7.9960.63 13.160.4 46.363.6 11.560.2
384 24 4.2662.03* 1.8960.30** 8.3160.19 16.160.2** 45.260.5 10.760.1
48 2.6060.71* 4.2860.87 7.3660.38 12.860.3 40.661.3 12.760.2**
aValues are means6SEM for n=5, except for 199 and 398 mg/kg 2,4DNT at 48 h where n=4 and 199 mg/kg 2,6DNT at 48 h where n=3 and for 398 mg/kg 2,4DNT at
24 h where individual values are shown. Means that differed from concurrent vehicle controls (0 mg/kg) are indicated by * or ** for p,0.05 or 0.01, respectively.
bAbbreviations. HbG=hemoglobin, HCt=hematocrit, RDW=red blood cell distribution width, Retic=reticulocytes.
doi:10.1371/journal.pone.0014662.t003
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few significantly affected GO terms. Four significantly up-
regulated functional terms were shared by all 5 compounds
(Table 6). The top significantly changed GO terms regulated by all
5 compounds were ‘‘metabolic process’’ and ‘‘cellular metabolic
process’’ (a child term under metabolic process), protein folding,
and ‘‘xenobiotic metabolic process’’ (a child term of ‘‘response to
xenobiotic stimulus’’).
Twenty significantly up-regulated GO functional terms were
shared by 2,4DNT, 2,6DNT, 4ADNT and TNT, among which at
least half were child terms of ‘‘metabolic process’’ and ‘‘cellular
metabolic process’’. Primarily, these terms could be categorized as
‘‘macromolecule metabolic process’’, ‘‘RNA metabolic process’’
and ‘‘cellular biosynthetic process’’. The major term under
macromolecule metabolic process was cellular protein metabolic
process, under which a significant common term was protein
folding.
The functional term ‘‘cellular biosynthetic process’’ was more
enriched in response to TNT, 4A DNT than 2,4DNT and
2,6DNT treatments (Table 6). NQO1, represented in ‘‘xenobiotic
metabolic process’’ and in the ‘‘cellular biosynthetic process’’, was
up-regulated by all 5 compounds indicating this gene may play an
important role in the response to all 5 compounds.
Under the functional term ‘‘RNA metabolic process’’, pirin
(PIR) was up-regulated by 2,6DNT, 2ADNT, 4ADNT and TNT.
Tryptophanyl-tRNA synthetase (WARSs) was induced by
2,6DNT, 4ADNT and TNT; small nuclear ribonucleoprotien
polypeptide A (SNRPA), NHP2-like protien1 (NHP2L1) was up-
regulated by 2,4DNT, 4ADNT and TNT. 2,4DNT, 2,6DNT and
4ADNT shared more induced genes of ‘‘RNA metabolic process’’
which included the gene for absent, small, or homeotic-like gene
(ASH2), general transcription factor II H, polypeptide 1
(GTF2H1), EBNA1 binding protein 2 (EBNA1BP2), nucleolar
protein 5A (NOL5A), peptidylprolyl isomerase (cyclophilin)-like 3
(PPIL3) and tRNA splicing endonuclease 2 homolog (Saccharomyces.
cerevisiae) (TSEN2).
Other shared up-regulated functional terms included ‘‘mito-
chondrion organization and biogenesis’’ as well as ‘‘protein
transport’’ (Table 6). Interestingly, some genes present in earlier
categories such as P53, HSPD1 also fit into both categories. The
gene translocase of inner mitochondrial membrane 9 (TIMM9)
found under both categories, was more strongly induced by
2,4DNT and 2,6DNT.
Further comparison of up-regulated GO functional terms of
2,4DNT, 2,6DNT and 4ADNT revealed a high number of shared
terms, 65 terms. ‘‘DNA metabolic process,’’ a child term of
Table 4. Effect of 2ADNT and 4ADNT on Hematology Outcomes
a.
Dose Time Granulocytes Lymphocytes Erythrocytes HbG
b HCt RDW
mg/kg hr 10
6/mL 10
6/mL 10
9/mL g/dL % %
2ADNT
0 24 0.5460.19 5.0760.56 7.7060.15 14.760.3 43.660.7 10.660.1
48 0.7660.19 3.7560.50 6.8360.07 13.260.1 41.260.3 11.160.0
4 24 0.8560.06 5.7560.40 7.6760.07 14.760.1 44.060.4 10.660.1
48 0.4060.15 3.7160.56 6.8060.10 13.160.2 40.760.6 11.260.1
44 24 0.6060.19 4.2360.21 8.0560.11 14.560.6 45.860.4 10.860.1
48 0.4560.14 4.1360.36 7.0560.16 13.660.2 42.460.8 11.060.1
87 24 0.7360.25 3.4660.37 7.4160.27 14.360.4 42.961.7 10.660.1
48 0.8360.11 4.0160.24 6.9560.14 13.460.3 41.760.9 10.960.1
174 24 0.7060.17 3.9460.40 7.3760.19 14.760.3 42.761.1 10.660.1
48 0.9260.21 4.6260.972 7.0560.19 13.360.4 41.561.1 10.960.1
348 24 0.5060.18 3.8460.14 7.6660.14 15.3, 12.7 43.960.9 11.060.1
48 0.7660.10 3.4060.36 6.8060.08 12.760.1 40.360.5 10.960.2
4ADNT
0 24 1.2260.17 5.2660.60 7.4460.20 14.560.3 42.861.0 11.060.1
48 1.0960.369 4.8060.81 7.1460.12 13.460.3 41.760.6 10.860.1
5 24 0.8860.13 4.3060.59 7.7760.11 14.960.3 44.660.7 10.660.1
48 1.9260.40 5.4860.62 6.6760.11 12.860.2 39.460.5 10.460.1
47 24 1.2060.09 4.5660.31 7.8260.13 15.160.1 45.060.4 10.960.1
48 1.8760.24 5.5260.90 6.9460.12 13.360.1 40.960.4 10.560.1
94 24 1.0860.15 4.3060.32 7.6060.14 14.760.4 43.661.0 10.760.1
48 1.7760.53 5.7461.10 6.4560.17* 12.260.2** 37.860.7** 10.860.1
187 24 1.0860.04 4.7160.32 7.6660.05 14.960.2 44.660.3 10.760.1
48 1.0660.29 4.5960.36 6.6360.16 12.560.3* 39.060.8* 10.660.1
374 24 1.3060.16 3.7860.30 7.7660.19 15.160.3 44.460.9 10.760.1
48 2.1560.37 4.9760.78 6.9260.14 13.160.2 41.060.7 10.660.2
aValues are means6SEM for n=5. Means that differed from concurrent vehicle controls (0 mg/kg) are indicated by * or ** for p,0.05 or 0.01, respectively.
bAbbreviations. HbG=hemoglobin, HCt=hematocrit, RDW=red blood cell distribution width.
doi:10.1371/journal.pone.0014662.t004
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process’’ and ‘‘biopolymer metabolic process’’, was a key term
shared by the 3 compounds.
When down-regulated GO biological process terms were
compared, 2,4DNT and 2,6DNT were more similar than other
compounds (Table 7). This high similarity is consistent with the
up-regulated GO biological process terms and gene expression
profiles as described earlier. Such correlation suggests that these
two compounds have highly similar molecular modes of action.
‘‘Lipid biosynthetic process’’, which is highly related to ‘‘lipid
metabolic processes’’, was affected by all compounds (Table 8).
Two critical downstream GO terms of ‘‘lipid metabolic process’’
were ‘‘fatty acid metabolic process’’ and ‘‘sterol metabolic
process’’. ‘‘Amino acid metabolic process’’ and/or its child terms,
‘‘organic acid metabolic process’’ and ‘‘carboxylic acid metabolic
process’’, were significantly down-regulated by 2,4DNT, 2,6DNT,
2ADNT and TNT.
The second common significantly down-regulated GO biolog-
ical process term was ‘‘immune system process’’ under which
‘‘immune response’’ was also affected. Both terms were more
enriched in 4ADNT and TNT exposures than with exposure to
the other 3 compounds(Table 9). Our results suggest that these
chemicals affect immune response and chemokine signaling.
Pathways influenced by all the 5 compounds
To further explore the molecular mechanisms, we used the most
significantly differentially expressed transcripts of each chemical
exposure to perform canonical pathway analyses. In general, a
number of pathways were common between any compound pair
(Table 10). Five pathways were strongly affected by all 5
compounds (File S1). The common pathways were also generally
present in the top significant pathways affected by the compounds
(Figure 8). The most significantly regulated genes are listed in File
S1 for each pathway regulated by each compound. There were 5
pathways that were significantly regulated by 4 of the 5
compounds (File S1). Xenobiotic metabolism signaling and
metabolism of xenobiotics by cytochrome P450 pathways were
highly enriched in 2,6DNT, 4ADNT, 4ADNT and TNT exposure
gene expression profiles. Propanoate metabolism, fatty acid
metabolism and valine, leucine and isoleucine degradation
pathways were strongly affected by 2,4DNT, 2,6DNT, 2ADNT
and TNT. Nearly half of these 10 commonly impacted pathways
(File S1), belong to amino acid metabolism, suggesting that amino
acid metabolism plays a critical role in the compounds’ effects
which is consistent with Gene Ontology analysis.
Examination of the most significantly regulated genes in
pathways reveals that a number of genes from a few different
gene families play a repeated role in multiple pathways that were
regulated by chemical exposures. These gene families included
aldehyde dehydrogenase 1 (ALDH1), gluathione S-transferase
(GST), heat shock protein (HSP), and cytochrome P450 (CYP)
families. ALDH1 family is involved in all the common pathways
except NRF2-mediated oxidative stress response. The most
significant differentially expressed genes under this family included
ALDH1A1, ALDH1A3, ALDH1B1, ALDH1L1, and ALDH1L2.
They were strongly up-regulated by at least two compounds, with
some members affected by 3 compounds. For example, the family
member ALDH1B1 was regulated by 2,4DNT, 2ADNT, and
4ADNT while ALDH1L1 was significantly affected by 2,4DNT,
4ADNT and TNT. Several genes in the GST family including
GSTM1 (muscle), GSTM2, GSTM3, GSTM4 or GSTM7-7,
GSTM5, GST pi1(GSTP1) and GST theta 1(GSTT1) participate
in at least half of the commonly affected pathways (File S1). These
genes were more likely to be up-regulated by the compounds.
The most significantly regulated genes shown in the commonly
affected pathways in the HSP family included HSP 90KDa alpha
(cytosolic), class A member 1(HSP90AA1), heat shock 27kDa
protein 1 (HSPB1), HSP 90kDa alpha (cytosolic), class B member1
(HSP90AB1), and heat shock 22kDa protein 8 (HSPB8). These
genes were usually up-regulated and involved in the following
common pathways: aryl hydrocarbon receptor signaling, xenobi-
otic metabolism signaling, and NRF2-mediated oxidative stress
response. We have found that HSP genes were highly enriched in
the GO biological process term, ‘‘response to xenobiotic stimulus’’.
Since xenobiotic metabolism signaling also encompasses aryl
hydrocarbon receptor signaling, and NRF2-mediated oxidative
stress response, the pathway analysis results are consistent with the
GO analysis indicating that heat shock proteins play an important
role in the response to exposure to the 5 compounds.
A large number of differentially expressed genes belonged to the
cytochrome P450 family (CYP1A1, CYP1A2, CYP3A5,
CYP3A43, CYP4A11, CYP7A1, CYP51A1, CYP2C7, CYP2C44,
CYP2C70, CYP2D6, CYP2D12, CYP2D26, CYP4F8, and
CYP2J9. They mainly took part in the following common
pathways: aryl hydrocarbon receptor signaling, LPS/IL-1 medi-
Figure 3. Morphology of erythrocytes from rats treated 24 h
earlier with 2,6DNT. Photomicrographs at high magnification (100X
objective with oil) of wedge preparations of blood vitally stained with
new methylene blue are shown. Blood from rats treated with 199 (A)
and 99 (B) mg/kg 2,6DNT are shown. Reticulocytes with blue stained
mRNA are indicated by asterisks and arrows point to erythrocytes with
indentations (bite cells).
doi:10.1371/journal.pone.0014662.g003
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and metabolism of xenobiotics by cytochrome P450. These CYP
family genes were primarily up-regulated by all the compounds.
Although there was no common significant cell death signaling
pathways involved in the expression profiles induced by these
compounds, different pathways associated with cell death signaling
were strongly impacted. Apoptosis and/or P53 signaling were
evidently affected by two and more of these compounds. Three
genes which were commonly regulated by two or more
compounds were P53, Bcl2-associated X protein (Bax), and
caspase 3(CASP3). Some pathways such as estrogen receptor
pathway and nucleotide excision repair pathway were only
significantly regulated by 2,4DNT and 2,6DNT. Antigen
presentation pathway was only evidently affected by TNT.
Nitrotoluenes impact common gene networks
To further understand the common mechanisms, we looked for
differentially expressed genes in common with all five chemical
exposures. Fifty-four transcripts corresponding to 47 non-redun-
dant genes were significantly affected by at least four of the 5
compounds (Table S11). We constructed several networks using
the 47 genes. Interestingly, one significant network was associated
with hepatic system disease and liver cholestasis (Figure 9A)
suggesting this network could present a common mechanism for
possible induction of hepatoxicity seen with exposure to 2,4DNT,
2,6DNT and TNT. Although no adverse effects were seen with the
chemicals 2ADNT and 4ADNT, the shared network suggests the
potential for some effects similar to the other chemicals under
prolonged exposure conditions. Several shared up-regulated genes
including ABCC3, PRMT7, GSS, SNRPA, PANX2, MRPL24,
and ALDH1L1 all connected with hepatocyte nuclear factor 4
alpha (HNF4A). While HNF4A was not a common altered gene,
as a central transcription factor in this network, it may be
important in modulating the effects caused by these chemicals.
Genes involved in NRF2-mediated oxidative stress response
pathway were also found in the network.
Based upon evidence that the nitrotoluenes impacted a common
gene network related to liver effects, we next examined each
chemical exposure for specific gene networks related to liver
function. To fulfill this goal, we employed the significantly
Figure 4. The dose and time dependent numbers of transcripts regulated by 2,4DNT, 2,6DNT, 2ADNT, 4ADNT or TNT. Rats were
exposed to one of the 5 compounds for 24 h (blue line) or 48 h (red line), with one of 4 doses plus vehicle controls. Rats were sacrificed and liver
tissues were employed for total RNA isolation and microarray hybridization and analysis as described in Materials and Methods. The numbers of
transcripts at Y axis were achieved by comparing the gene expression profiles of animals treated with one of four doses with respective control
animals at the time point 24 h or 48 h for one of the compounds.
doi:10.1371/journal.pone.0014662.g004
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associated with liver function to build gene networks based on
Ingenuity knowledge base. Specific significant gene networks that
were associated with hepatic system function, liver cholestasis and/
or liver damage were generated for each compound (Figures 9B–
F). Several transcription factors such as NFE2L2 (NRF2), EGR1,
JUND, and SREBF1 were highly connected in the 2,4DNT
affected gene network, indicating these genes may play a role in
2,4DNT impacts on liver (Figure 9B). In the 2,6DNT regulated
gene network, the genes CDKN1A, PAK1, ITGAV, and NFE2L2
(NRF2) were highly connected (Figure 9C) suggesting these genes
are important in 2,6DNT effects on liver. Interestingly, the highly
connected genes in the TNT regulated gene network (Figure 9F)
were largely involved in immune response. These genes consisted
of CXCL10, CCL13, TNFSF10, NOS3 and CCND1 and may
play a major role in TNT adverse effects on the liver.
In the 2ADNT affected gene network, CDKN1A and ABCC3
were greatly connected (Figure 9D), indicating possible roles in
2ADNT affected potential liver function. Genes including
HMOX1, PRKCz, PKC, Raf, and RAF1 were highly connected
in the gene network responsive to 4ADNT (Figure 9E). These
genes could play more important roles in potential liver effects
regulated by 4ADNT.
Despite the different topologies and gene compositions of the
networks, a number of common pathways that were modulated by
all compounds and were also present in all sub networks. These
included NRF2-mediated oxidative stress response, aryl hydro-
carbon receptor signaling, xenobiotic metabolism signaling, LPS/
IL-1 mediated inhibition of RXR function, and xenobiotic
metabolism signaling pathways.
Verification of microarray responses using real time QRT-
PCR
To verify the credibility of microarray data, we first selected 96
genes that are responsible for oxidative stress (Table S12) to
perform real time quantitative reverse transcriptase PCR (QRT-
PCR). Real time qPCR studies were conducted using vehicle
control samples and 199 mg/kg 2,4DNT samples at either 24 or
48 h time points. The same RNA was used for QRT-PCR as was
used for microarray assessment. We found a surprising consistency
between the two approaches. The significantly regulated gene
numbers by 2,4DNT were exactly the same for both QRT-PCR
and microarray, 32 for 24 h and 34 for 48 h (File S1). Moreover,
both methods were identical for the positive and negative
directions of all the genes between both time points (File S1). A
regression coefficient of 0.93 between the two approaches for both
time points was achieved (File S1).
Previous studies by Wintz et al.[2] found that 24DNT impacted
oxygen transport and lipid metabolism in livers of the fish fathead
minnow (Pimephales promelas) via interaction with hemoglobin
and peroxisome proliferator activated receptor alpha (PPARa)
pathways. We examined whether similar impacts are observed in
Figure 5. Total transcript numbers regulated by the five compounds. Rats were treated with different compounds with variant doses and
microarray experiments were performed as described in Materials and Methods. The number of transcripts that were at each time point was analyzed
using One-Way ANOVA with a Benjamin-Hochberg false discovery rate less than 0.05 across various doses at each time point (24 h or 48 h) for each
compound. The total regulated transcript number for each compound was calculated by summarizing the numbers of both time points (24 h+48 h),
and overlapped transcripts were only counted once. The relative up or down-regulated transcripts were obtained by comparing averaged animal
samples with various dose treatments with respective control animal samples at each time point or both time points.
doi:10.1371/journal.pone.0014662.g005
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profiles, genes peroxisome proliferator activated receptor alpha
(PPARa), transferrin (TF), apolipoprotein B (APOB), and alpha
Hemoglobin (aHG) were chosen to carry out QRT-PCR across all
samples including different compounds, doses, and time points
(File S1). Correlations of 0.71 and 0.85 were observed between the
results of QRT-PCR and microarrays (File S1). In fathead
minnows, the gene TF was down-regulated in livers of fathead
minnows exposed to 24DNT. Here, expression of TF was also
attenuated by 2,4DNT at 24 h, in addition to 2,6DNT at 24 and
48 h with clear dose responses for both QRT-PCR and
microarray with R
2=0.79 (File S1). The gene PPARa has been
shown to be repressed by 2,4DNT in liver of exposed fathead
minnow. PPARa was also down-regulated by 2,4DNT at 24 h in
rat with a strong dose response. PPARa was consistently
suppressed by 2,6DNT at 24 h and 48 h but up-regulated by
2ADNT and TNT at 48 h. Microarray and QRT-PCR data had
an R
2=0.84. Other genes such as APOB were reported to be
down-regulated in fathead minnows exposed to 2,4DNT while
alpha Hemoglobin (aHG) was up-regulated. Hepatic nuclear
factor 4, alpha (HNF4A) was not affected by 2,4DNT in fathead
minnows. HNF4A had no significant change with exposure to the
five chemicals (not shown).We saw similar impacts on these 3
genes by 2,4DNT in rat livers by both QRT-PCR and microarray
(File S1). While APOB was up regulated by all chemicals, aHG
was up regulated by 24DNT but it was primarily down-regulated
by other compounds (File S1). Microarray and QRT-PCR data
for APOB and aHG had R
2 values of 0.75 and 0.71 respectively
(File S1).
QRT-PCR analysis of genes found in networks and
affected pathways
QRT-PCR analysis of select genes present in gene networks and
affected pathways were performed including GSTM4, NRF2,
ALDH1A1, and fatty acid binding protein 2 (FABP2) had R
2
values of 0.85, 0.83, 0.73, and 0.72, respectively, when compared
to microarray data across all samples (File S1). Differential effects
were seen on NRF2 expression with up-regulation at 24 h with
2,4DNT and 2,6DNT while it was down-regulated at 24 h with
2ADNT, 4ADNT and TNT. At 48 h, NRF2 expression was up-
regulated with 2,4DNT, 2ADNT, 4ADNT and TNT while no
significant effect was seen with 2,6DNT exposure. GSTM4
expression was consistently up regulated at 24 h by all five
chemicals. Differential effects due to nitrotoluene exposure were
observed on expression of ALDH1A1. 2,4DNT up-regulated
ALDH1A1 at both 24 and 48 h. 2,6DNT down-regulated
ALDH1A1 at 24 h while producing little consistent effect at
48 h. 2ADNT up-regulated expression at 24 h and down-
regulated expression at 48 h. 4ADNT up-regulated expression at
24 and 48 h. TNT had a slightly inconsistent effect but generally
up-regulated ALDH1A1 expression at both 24 h and 48 h. Fatty
acid binding protein 2 (FABP2) was up-regulated by all chemicals
except 2,6DNT which only up-regulated FABP2 at a single dose
and time.
Figure 6. Hierarchical clustering of experimental conditions. Experimental conditions were based on averaging samples with the same dose
treatments of a compound for 24 h or 48 h and total 40 experimental conditions were used for the clustering. Transcripts used for making these
conditional trees were selected based on filtering on flags. Only a transcript that was presented in at least 50% samples was chosen for clustering.
Pearson correlation algorithm with average linkage was conducted to calculate distances between conditions.
doi:10.1371/journal.pone.0014662.g006
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metabolism
The enrichment in GO biological process related to lipid
metabolism and pathways including fatty acid metabolism and
NRF2-mediated oxidative stress response in addition to data from
other species suggests that nitrotoluenes exposure would signifi-
cantly impact lipid biosynthesis in liver. To validate this we
analyzed lipid metabolites in livers of the exposed rats. Two doses
were selected at 24 h to measure lipids levels, the second lowest
and the highest, and vehicle control of the 5 compounds. A total of
340 lipid species (Table S13) belonging to 12 lipid classes were
measured using a mass spectrometry approach [19,20]. One-Way
ANOVA with a multiple adjustment (p value ,=0.05) was
applied to identify differentiated lipid species for each compound.
2,4DNT, 2,6DNT and TNT had stronger impact on the
regulation of lipid profiles than 2ADNT and 4ADNT. Overall,
more lipid species were down-regulated by the compounds.
Thirty-six lipid species were commonly affected by at least 3 of
the 5 compounds (Figure 10A). Of them, 21 lipid species were
commonly down-regulated in response to 2,4DNT, 2,6DNT and
TNT: Nine PC with one ether-linked (alkyl or alkenyl) chain
(ePC), 8 phosphatidylcholine (PC), and 4 phosphatidylethanol-
amine (PE). Phosphatidylinositol (PI 38:5; phospholipid species are
indicated by total acyl carbons:total acyl carbob-carbon double
Figure 7. Hierarchical clustering of significantly regulated genes. Most significantly regulated transcripts of each compound were used for
constructing gene clustering trees across different conditions including control and 4 different doses at 24 h or 48 h for each compound. Pearson
correlation algorithm with average linkage was performed to calculate distances between transcripts. Two distinctive gene expression patterns: early
up-regulated (early up) and early down-regulated (early down) gene expression patterns were indicated on the right of each cluster.
doi:10.1371/journal.pone.0014662.g007
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pounds. Only 3 lipid species, PC 34:2, PE 34:2 and PE 36:2 were
up-regulated by all the compounds. The lipid species lysoPC 18:3
was decreased by 2,4DNT, 2,6DNT, 2ADNT and 4ADNT but
increased by TNT. PS 38:5 was down-regulated by 2,4DNT,
2,6DNT, 2ADNT, and TNT but up-regulated by 4ADNT.
Interestingly, no matter whether a lipid species was up or down-
regulated, a strong dose effect was observed (Figure 10A). We also
compared total lipid species differences in each lipid class. There
were more total lipids that were down-regulated by 2,4DNT,
2,6DNT, 2ADNT and TNT except 4ADNT (Figure 10B). Total
ePC, ePE were commonly down-regulated by all the compounds.
There was no single lipid class that was commonly up-regulated by
all 5 compounds. The amount of total PA was reduced in response
to 2,4DNT, 2,6DNT, 2ADNT and TNT but was elevated in
response to 4ADNT. Total PS was up in response to 2,4DNT,
2,6DNT and 4ADNT but down to 2ADNT and TNT. Lipidomics
results of an overall down-regulated lipid profile are well
correlated with the gene expression profiles where lipid metabo-
lism was predicted to be inhibited.
Discussion
In the present study, we have used a systems biology approach
in order to understand effects of the 5 similarly structured
nitrotoluenes on signaling pathways via liver gene alteration and to
gain insight into the mechanism of toxicity of this class of
compounds. An integrative approach was employed in our study
which included clinical toxicology, pathology, transcriptomics,
lipidomics, gene function classification, pathway analysis and gene
network modeling. Overall, we found that the expression results
correlated well with toxic and pathological results. For instance,
we have found more genes that were significantly changed in
response to 2,4DNT and 2,6DNT than TNT, 4ADNT, and
Table 5. Comparison of significantly functional terms up-
regulated by the 5 compounds.
2,4DNTup 2,6DNTup 2ADNTup 4ADNTup TNTup
2,4DNTup 148(100%) 90(60.8%) 7(8.5%) 80(53.1%) 44(21.8%)
2,6DNTup 148(100%) 6(7.3%) 76(50.5%) 28(25.9%)
2ADNTup 15(100%) 14(16.6%) 10(24.1%)
4ADNTup 153(100%) 53(50.0%)
TNTup 68(100%)
Note: The numbers outside of a bracket are calculated based on the common
functional terms between two compounds. The number inside a bracket is the
similarity rate which is calculated as that the number of common functional
terms divided by the averaged total functional terms of two compared
compounds.
doi:10.1371/journal.pone.0014662.t005
Table 6. Commonly most significantly up-regulated functional terms based on biological process of Gene Ontology in response to
the compounds.
Functional terms 2,4DNT 2,6DNT 2ADNT 4ADNT TNT
metabolic process 5.86E-14 4.63E-14 0.0062795 6.63E-20 1.09E-14
cellular metabolic process 3.86E-15 7.60E-14 0.007577 1.46E-22 8.44E-13
cellular macromolecule metabolic process 0.0072135 2.89E-07 4.56E-06 0.001380
cellular biosynthetic process 0.0046218 0.02843983 2.71E-12 1.64E-13
macromolecule metabolic process 9.03E-13 1.37E-15 4.79E-08 0.039807
cellular macromolecule metabolic process 0.0072135 2.89E-07 4.56E-06 0.001380
cellular protein metabolic process 0.0058248 2.67E-07 3.27E-06 0.002308
protein metabolic process 0.0038298 4.97E-09 7.26E-06 0.003270
cellular protein metabolic process 0.0058248 2.67E-07 3.27E-06 0.002308
protein folding 1.10E-05 1.99E-04 0.083242 3.49E-06 0.005908
RNA metabolic process 1.47E-11 3.04E-05 3.33E-04 0.004
primary metabolic process 1.13E-14 5.91E-14 2.76E-17 1.54E-08
protein metabolic process 0.0038298 4.97E-09 7.26E-06 0.003270
response to xenobiotic stimulus 0.0680837 0.005775329 8.52E-07 1.96E-04 1.43E-04
xenobiotic metabolic process 0.0626892 0.004970058 7.40E-07 1.61E-04 1.21E-04
macromolecule localization 4.38E-06 2.06E-07 3.73E-04 0.043349
protein localization 1.79E-05 3.46E-06 6.88E-04 0.030145
establishment of protein localization 3.49E-06 1.13E-06 0.001733 0.016687
protein transport 7.66E-06 2.73E-07 0.0010188 0.007891
Cellular process
organelle organization and biogenesis 4.69E-06 8.47E-08 9.23E-06 0.049135
mitochondrion organization and biogenesis 0.0330679 7.40E-04 0.0066755 0.009797
intracellular transport 8.49E-07 3.94E-12 0.0032581 0.004579
intracellular protein transport 3.58E-07 1.46E-05 0.002939 0.008296
protein targeting 4.59E-07 3.97E-04 2.44E-04 0.013345
doi:10.1371/journal.pone.0014662.t006
Mechanisms of Nitrotoluenes
PLoS ONE | www.plosone.org 14 February 2011 | Volume 6 | Issue 2 | e146622ADNT. Interestingly, we found that the number of regulated
genes was greater at 24 h than 48 h by all compounds except
TNT. Animals might take more time to metabolize TNT to an
unidentified reactive metabolite, which could be a reason why
TNT impacts more genes at 48 h than 24 h. The difference in the
amount of differentially expressed genes, distinctive gene expres-
sion patterns, specific regulated gene lists, pathways and unique
gene networks, suggest a specific molecular mechanism for each
compound. Although we observed clinical and histo-pathological
differences caused by the compounds, we could still see some
common biological processes that were affected by two or more
compounds, which involve DNA damage response and cell death
signaling, detoxification response, de-regulation of lipid metabo-
lism and impaired immune response.
DNA damage response and cell death signaling
Chemicals, irradiation, or other environmental factors can
induce DNA damage response which results in cell death via cell
cycle arrest [21]. Several earlier studies reported that 2,4DNT and
2,6DNT could cause cell death and genotoxic effects such as DNA
damage [22]. TNT and its metabolites have also been determined
to induce DNA fragmentation and damage [23]. 2,4DNT was
more potent than TNT in inducing DNA single strand breaks in
hepatocytes from livers of rats treated orally [24]. TNT and
2,4DNT could also possibly alter DNA sequence [25].
Our study has revealed that DNA metabolic process and DNA
damage response are major biological processes affected by these
compounds, which seem to be more significant with 2,4DNT,
2,6DNT and 4ADNT than TNT and 2ADNT. One possible
reason for the damage caused by these compounds is the ability to
impair DNA synthesis and replication through DNA adduction as
was discovered in hepatocytes exposed to 2,4DNT and 2,6DNT
[26]. Another potential reason is through endogenous oxidative
processes which are known to induce DNA damage [27].
Oxidative process is covered in detail in the next section. The
DNA damage activates ataxia telangiectasia mutated (ATM)
kinase and other kinases, leading to the activation of the tumor
suppressor p53 [28]. P53 is a transcription factor that has long
been recognized to play a key role in many biological processes
such as cell cycle, DNA repair, cell death and apoptosis [29,30].
Cell death signaling was also found to be induced by these
compounds. For instance, caspase 3, known to induce cell
shrinkage and DNA fragmentation that leads to cell death, was
up-regulated by the compounds [31].
Oxidative stress and detoxification response
One important pathway that could play a role in oxidative stress
and detoxification response is the NRF2-mediated oxidative stress
response pathway, which was commonly influenced by all the 5
compounds. NRF2 is a transcription factor which binds to the
antioxidant response element in the promoter of NRF2 regulated
genes [32]. Under normal conditions NRF2 is bound to Keap1 in
the cytoplasm [33]. A number of factors such as free radicals
reverse the sulfhydryl-dependent association between NRF2 and
KEAP1 and release NRF2, allowing it to enter into the nucleus.
The NRF2-mediated oxidative stress response has been
revealed to reduce toxicity and carcinogenesis during exposure
to electrophile or other environmental toxicants or inflammation
in mammalian models [34]. Recently, we found that NRF2 was
also induced in the liver of Northern bobwhite (Colinus virginianus)
treated with 2,6DNT [35] suggesting NRF2 mediated pathway is
functionally conserved across different species for the protection
from 2,6DNT.
Several NRF2 downstream phase I and II metabolizing
enzymes including GSTs (GSTM3, GSTM4, etc.), NQO1,
Aflatoxin B 1-aldehyde reductases (AKR7A3), epoxide hydrolase
1, microsomal (xenobiotic) (EPHX1) and UGT1A6 were signifi-
cantly induced by most of the compounds and may prevent cell
damage due to oxidative stress.
Another key pathway contributing to the detoxification process
is aryl hydrocarbon receptor (AHR) Signaling. AHR ligands bind
to the AHR complex inducing the dissociation of interacting
proteins, leading to the release of AHR which then complexes with
the aryl hydrocarbon receptor nuclear translocator (ARNT) and
facilitates transfer of the complex to the nucleus and subsequent
regulation of gene expression leading to biochemical and toxic
responses [36]. AHR signaling has been also reported to play a
role in detoxification [37]. AHR regulates expression of phase I
metabolizing enzymes in the aldehyde dehydrogenae (ALDH)
families. Two key members in this family, ALDH1A1 and
ALDH1L1, were significantly up-regulated by nearly all the
compounds. ALDH family genes have been well characterized as
protectors ROS caused oxidative damage. They metabolize
reactive products of toxic lipid peroxidation (LPO), which include
4-hydroxy-2-nonenal and malondialdehyde [38]. This could
explain why ALDH could contribute to the detoxification of the
Table 7. Comparison of significantly functional terms down-regulated by the 5 compounds.
2,4DNTdown 2,6DNTdown 2ADNTdown 4ADNTdown TNTdown
2,4DNTdown 127(100%) 61(54.2%) 8(11.3%) 2(2.3%) 9(12.3%)
2,6DNTdown 98(100%) 6(10.3%) 2(5.6%) 7(11.9%)
2ADNTdown 18(100%) 4(20.0%) 6(12.4%)
4ADNTdown 22(100%) 4(21.1%)
TNTdown 19(100%)
doi:10.1371/journal.pone.0014662.t007
Table 8. Commonly most significantly down-regulated
functional terms based on biology process of Gene Ontology
in response to the compounds.
Functional terms 2,4DNT 2,6DNT 2ADNT 4ADNT TNT
Lipid metabolic process 1.39E-14 6.79E-12 0.00198
Lipid biosynthetic
process 1.46E-10 0.000702 0.0159 1.46E-22 0.0129
Immune system process 1.99E-06 8.89E-05
Immune response 0.06268 0.004970 7.40E-07 1.61E-04 1.21E-04
doi:10.1371/journal.pone.0014662.t008
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nitroreductases.
The expression of many CYPs downstream of AHR signaling is
significantly regulated by these compounds, which include
CYP1A2, CYP3A5, CYP3A43, CYP4A11, CYP7A1, CYP51A1,
CYP2C7, CYP2C44, CYP2C70, CYP2D6, CYP2D12, CYP2D26,
CYP4F8, and CYP2J9 etc. An induction of CYPs via AHR
signaling is to enhance clearance of these compounds. However, if a
compound is present inexcess it will form an electrophilicnitrenium
cation that will adduct nucleophiles of DNA, e.g., guanine, and
proteins, e.g., hemoglobin as studied by Sabbioni et al.,[39].
Since these commonly regulated pathways such as NRF2-
mediated oxidative stress response, aryl hydrocarbon receptor
signaling and metabolism of xenobiotics by cytochrome P450
pathways are part of xenobiotic metabolism signaling, xenobiotic
metabolism signaling may play a pivotal role in the protection
against the toxicity from the compounds. A variety of phase I and
phase II metabolizing enzymes belonging to several gene families
including GSTs, CYPs, ALDHs, UGTs, and aflatoxin B1
aldehyde reductase (AFARs) seem to participate in all the
xenobiotic pathways.
In addition to NRF2, AHR, and P450 mediated pathways, the
constitutive androstane receptor (CAR) and the pregnane x
receptor (PXR) mediated pathways are part of xenobiotic pathway
as well [40]. ATP-binding cassette, sub-family C (CFTR/MRP),
member 3 (ABCC3), is a transporter protein and downstream
target for both CAR and PXR signaling, and its expression was
commonly elevated by the compounds and likely serves as a role in
the defense against the toxicity caused by the compounds [41].
GO analyses revealed that differentially expressed gene lists
were highly enriched in the biological process ‘‘protein folding’’ by
all the compounds. HSPs are well known stress response proteins
involved in multiple functions such as protein folding and
unfolding, cell survival and cell growth [42,43]. The expression
of HSPs, was significantly enhanced by all or some of the
compounds. HSPs also participate in xenobiotic metabolism
signaling pathway. Therefore, their induction by the compounds
should also contribute to the detoxification process.
Nitrotoluene effects on lipid metabolism
GO enrichment analysessuggestedthat ‘‘lipidmetabolicprocess’’
was a process significantly repressed by almost all the compounds.
Pathway analysis also found that two pathways with major roles in
lipid metabolism were affected: LPS/IL-1 mediated inhibition of
RXR function and fatty acid metabolism. Chemical analysis of
livers from these compounds exposed rats for 24 h confirmed
genomics evidence that lipids were adversely affected including
individual lipid species and total lipid classes. Down-regulation of
lipid metabolism associated genes leads to the reduction of lipid
metabolite products and possible energy production.
An important part of LPS/IL-1 mediated inhibition of RXR
function is PPAR/RXR signaling. Fatty acid oxidation in liver and
other tissues is regulated via the activation of nuclear hormone
receptors, including PPARs and FXR [44,45]. These nuclear
hormone receptors interact with RXR to activate gene transcrip-
tion. Recent studies have revealed that the expression of RXR,
PPARa, are decreased in liver, kidney, and heart after the
treatment of lipopolysaccharide (LPS) [46–48]. Both qPCR and
microarray results (File S1) show that PPARa was repressed by
2,4DNT and 2,6DNT, which was observed in fish [2].
A target of PPAR/RXR signaling, Acyl-CoA synthetase
ACSL5, was strongly down-regulated by 2,4DNT and 2,6DNT.
Other members Acyl-CoA synthetases such as ACSL1, ACSL2,
ACSL3 and ACSL4 were also affected by 2,4DNT and to some
extent 2,6 DNT. Acyl-CoA synthetases catalyze long chain fatty
acids to acyl-CoAs. Acyl-CoAs have a variety of metabolic fates in
the cell and can be employed to acylate proteins or be metabolized
through catabolic pathways such as b-oxidation or anabolic
pathways such as de novo synthesis and reacylation of triacylglycerol
(TAG), phospholipids, and cholesterol esters [49]. Acyl-CoAs have
also been reported to be involved in cell survival and lipid uptake,
therefore inhibition of Acyl-CoAs could affect cell survival and
normal lipid uptake [49].
In contrast to Acyl-CoAs, fatty acid binding protein 2 (FABP2),
another downstream target of PPAR/RXR signaling [50,51] was
induced by almost all the compounds. Fatty acid binding proteins
participate in the uptake, intracellular metabolism and/or
transport of long-chain fatty acids. They may also be responsible
in the modulation of cell growth and proliferation. Under normal
situations, fatty acid binding proteins bind to endogenous fatty
acids in the cytosol in mammals [52] enabling regulation of fatty
acid metabolism and maintenance of free fatty acids at less than
toxic concentrations [53]. Some recent studies have shown that
certain chemicals such as perfluorinated compounds (PFCs) can
dissociate the binding of FABPs to fatty acids by displacing them
from the protein [52] making them free to facilitate the
Table 9. Most significantly regulated genes involved in immune response for the 5 compounds.
Compounds Most significantly regulated genes
2,4DNT C4A, C5,C9,CXCL12,DPP4,EGR1,ITIH1, KDR, LTB, MASP1, RT1-S3
2,6DNT C4A,C4BPA,C5,C6,CFH,CFI,CXCL12,DPP4,EGR1,FOXN1,H2-T18,ITIH1,LTB,MASP1
4ADNT C1QG,CCL6,CCR5,CD83,CORO1A,ERAF,FCGR3A,GBP2,IL1B,IL6RA,LTB,LY86,PRKR,RT1-DA,RT1-S3,RT1-T24-1,SPN
TNT CCL2,CXCL10,CXCL9,CXCL13, CXCL12, OASL2,RT1-BB,RT1-DA,RT1-S3,TNFRSF14
doi:10.1371/journal.pone.0014662.t009
Table 10. Comparison of significantly canonical pathways
regulated by the 5 compounds.
2,4DNT 2,6DNT 2ADNT 4ADNT TNT
2,4DNT 44(100%) 18(46.8%) 15(38.9%) 12(31.2%) 17(43.0%)
2,6DNT 30(100%) 15(47.6%) 10(31.7%) 17(52.3%)
2ADNT 33(100%) 14(42.4%) 23(67.6%)
4ADNT 33(100%) 16(47.1%)
TNT 35(100%)
Note: The number outside of a bracket is the common pathway number
between two compounds. The number inside a bracket is the similarity rate
which is calculated as that the number of common pathways divided by the
total averaged pathway terms of two compared compounds.
doi:10.1371/journal.pone.0014662.t010
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nitrotoluenes possibly due effects similar to those found for PFCs.
In contrast, FABP2 is down-regulated by 2,4DNT in fish [2],
indicating a species specific mechanism for 2,4DNT impacted lipid
metabolism.
LIPC, FASN, and APOB are primarily downstream genes of
FXR/RXR signaling, which is also a part of LPS/IL-1mediated
inhibition of RXR function pathway. These genes were more
heavily repressed by 2,4DNT and 2,6DNT. Lipase, hepatic (LIPC)
is mainly involved in lipoprotein transport and metabolism of
HDL while FASN plays a major role in fatty acid synthesis. The
down-regulation of APOB supported by both qPCR and
microarray is in agreement with the observation in fish exposed
to 2,4DNT. The reduction of the expression of these genes could
impair normal lipid metabolism. Another recent study by our
laboratory has shown that FASN and APOB were also down-
regulated in the liver of Northern bobwhite (Colinus virginianus)
treated with 2,6DNT indicating universal biomarkers for impaired
lipid metabolism could be conserved across different species for the
compounds [35].
Immune response
Immune response is the most significant functional term for
those down-regulated genes by 4ADNT and TNT. The major
Figure 8. Most significantly canonical pathways regulated by the 5 compounds. Top ten pathways were selected to present for each
compound. Most significantly regulated transcripts of each compound were chosen to run the Ingenuity pathway tool. The bigger the -log(p-value)
of a pathway is, the more significantly the pathway is regulated. The threshold lines represent a p value with 0.05.
doi:10.1371/journal.pone.0014662.g008
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MHC class I. Its expression was repressed by almost all the
compounds. HLA-E is a ligand for receptors of both the adaptive
and innate immune systems. The binding of self-peptides
complexed to HLA-E by the CD94-NKG2A receptor of natural
killer (NK) cells is a critical checkpoint for immune surveillance by
NK cells. Additionally, HLA-E is recognized by the T-cell receptor
of alpha/beta CD8 T cells as well and contributes to the adaptive
immune response to invading pathogens or other xenobiotics[55].
The reduction of HLA-E expression by the compounds indicates
they could disrupt the normal immune protection system and
induce abnormal phenotypes such as inflammation or other
diseases.
Chemokine signaling is a major immune response that was
affected by the compounds. It seems different compounds may
target different chemokine signaling pathways. Chemokine (C-X-
C motif) ligand 12 (CXCL12 or SDF-1) was strongly down-
regulated by 2,4 DNT and 2,6DNT. It is a ligand for the G-
coupled receptor protein Chemokine (C-X-C motif) receptor
CXCR4. Activation of CXCR4 by CXCL12 is involved in many
biological functions such as cell migration, growth and survival.
The activation can also trigger leukemia cell movement to the
marrow microenvironment, where CXCL12 pushes leukemia cells
in close contact with marrow stromal cells that lead to growth and
drug resistance signals. The inhibition of the expression of
CXCL12 could make the cells more susceptible to the nitroto-
luenes. It seems there are many chemokine ligands that were
repressed by TNT, which include CXCL13, CXCL9, CXCL10,
etc. Interestingly CXCL9 and CXCL10 share the same G-protein
coupled receptor CXCR3. Therefore, these chemokines possess
the capability of maintaining the normal immune function and the
protection against infectious agents and other external toxicants
[56,57]. CXCR3 was significantly down-regulated, particularly by
TNT but whether CXCR3 is a direct target of TNT needs to be
further examined.
Correlation of gene expression and lipid profiles with
adverse effects
Our toxicity studies have shown that overall dinitrotoluene
compounds, 2,4DNT, 2,6DNT and TNT had stronger toxic
effects than amino-dinitrotoluene compounds 2ADNT and
4ADNT, among which it seems that 2,4DNT and 2,6DNT are
more toxic than TNT. For example, we only observed lethality of
rats with 2,4DNT and 2,6DNT treatments. Another unique effect
of 2,4DNT, 2,6DNT and TNT exposure was hepatic sinusoidal
congestion. We found that erythrocytosis was associated only with
dinitrotoluenes 2,4DNT and 2,6DNT. These results were reflected
by the overall number of genes whose expression was changed.
2,4DNT, 2,6DNT had more gene expression changed than TNT,
2ADNT and 4ADNT. Our gene expression analysis also showed
that 2,4DNT and 2,6DNT share more similar gene expression
pattern than the other compounds.
At 48 h, TNT affected more changed gene numbers than
2ADNT and 4ADNT. 2ADNT had the least change in gene
number, which may be linked to its weak effects on body and
normalized liver weight and no change in RBC parameters or
blood granulocytes.
We found that body weight gain was decreased by all the
compounds. One probable reason for this observation was the
reduction of food consumption due to nitrotoluene exposure. A
reduction in food consumption may also play a role in the
observed down-regulation of energy metabolism. Our gene
expression and lipid profiles clearly show that energetic related
lipid metabolism is decreased, which supports this statement.
Liver weight increase, as seen in rats exposed to TNT and
4ADNT at 48 h, is indicative of enzyme induction including
cytochrome P450s and GSTs. Many of these enzymes were
induced at both 24 h and 48 h by the nitrotoluenes. Lipid
metabolism especially fatty acid metabolism, [58] and PPAR
signaling are associated with liver weight increase [59]. The gene
expression did show that fatty acid metabolism and PPAR
signaling were affected by the compounds. Mounting evidence
has shown that ROS can cause liver weight increase [59,60], and
our gene expression results indeed implicate ROS could be
produced by these compounds.
The most remarkable effect we observed from the hematology
assessment was erythrocytosis induced by the dinitrotoluenes.
Even though we did not find anemic effects induced by 2,4DNT as
have been reported in other studies, we did see decreased
hemoglobin and hematocrit in 4ADNT exposed animals after
48 h. One possible reason why anemia was not observed in our
studies is that we conducted an acute exposure design; the other
studies where anemia was seen are all repeat dose studies.
In our study, expression of several genes related to erythrocy-
tosis and oxygen transport such as hemoglobins and transferrin
were affected by the dinitrotoluenes. Numerous blood parameters
were unchanged or decreased in contrast to the hematological
parameters associated with erythrocytosis. This suggests that the
latter did not result from hemoconcentration as might occur if
dehydration occurred.
By purposely looking at erythropoietin signaling genes such as
erythropoietin and its receptor, we found that their expression was
also altered. Hemoglobin adduct formation due to nitrotoluene
exposure has been reported and may adversely affect oxygen
transport [39]. Hematotoxicity could be the direct toxicity of these
compounds followed by sinusoidal congestion and hepatoxicity
such as, necrosis, inflammation, toxicities to other organs and even
lethality because the delivery of oxygen to tissues is impaired.
Although extensive hepatotoxicity was not generally observed in
our short experimental design, some evidence such as the
sinusoidal congestion in histopathology after 2,6DNT, 2,4DNT
and TNT treatments and liver toxicity related gene expression
could predict more serious hepatoxicity with longer and continued
exposure. That hepatotoxicity might ensue as a time-dependent
secondary effect of hematotoxicity is supported by the observation
[61] that mechanism of action of dinitrotoluenes on cytotoxicity of
isolated rat hepatocytes in culture differs from any of the pathways
implicated by gene expression changes in our whole animal
exposures.
Figure 9. Common and specific gene networks related to liver toxicity induced by the compounds. The common gene network (A) was
constructed using commonly significantly regulated genes by at least four of the compounds. For constructing specific gene networks related to liver
toxicity of 2,4DNT(B), 2,6DNT(C), 2ADNT(D), 4ADNT(E) and TNT(F), only significantly regulated genes involved in known function to liver or
hepatoxicity or liver diseases were selected for each compound. The red and green highlighted genes represent up-regulated and down-regulated
genes respectively by one of the compound. The orange highlighted genes are involved in NRF2-mediated oxidative stress response. The up or
down-regulated genes in the networks were determined by comparing the averaged treatments with relative controls of a compound. The gene
networks were built using the Ingenuity knowledge base tool. The networks scores described in Materials and Methods for all the networks were
bigger than 10.
doi:10.1371/journal.pone.0014662.g009
Mechanisms of Nitrotoluenes
PLoS ONE | www.plosone.org 19 February 2011 | Volume 6 | Issue 2 | e14662Figure 10. Hierarchical clustering of commonly significantly regulated lipid species in response to 2,4DNT, 2,6DNT, 2ADNT, 4ADNT
and TNT. Rats were treated with 2,4DNT, 2,6DNT 2ADNT, 4ADNT or TNT with one of 3 doses including controls for each compound for 24 h. Rats
were sacrificed and liver tissues were used for lipid extraction and lipid profile measurement as described in Materials and Methods. Actually the same
samples were also used for the microarray studies. 36 individual lipid species (A) and 9 total lipid classes (B) that were significantly commonly
regulated by at least 3 of the compounds. Significantly regulated individual lipid species or lipid classes were determined using One-Way ANOVA
with a multiple adjust p value less than 0.05 across various doses of a compound.
doi:10.1371/journal.pone.0014662.g010
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[62]. Interestingly, we found that many genes in this pathway were
up-regulated by 2,4DNT, 2,6DNT and TNT. For instance, casein
kinase 1, delta(CSNK1D), HSP90AA1, AP-1, MDM2, ubiquitin
conjugating enzyme E2D2 (UBE2E2), UBE2M, UBE2N and P53
were induced by 2,4DNT (File S1). The presence of hypoxia could
also induce ROS production, inflammation, oxidative stress and
inflammation.
Integrative model for the common mechanisms
An integrative analysis of physiological endpoints, gene
ontology, pathways, and gene networks across different aspects
we were able to determine a possible mechanism of liver toxicity
due to exposure of these nitrotoluenes (Figure 11). DNA damage
response is a major functional term under DNA metabolic process
and is possibly due to direct damage by the chemicals or reactive
oxygen species (ROS), which are produced as side products of
phase I metabolizing enzymes such as CYPs. These enzymes are
mainly under the functional term protein process, and are involved
in the xenobiotic metabolism signaling pathway. The protein
PPARa, controls expression of lipid metabolism genes (apolipo-
proteins and fatty acid metabolism genes) as well as transferrin
(TF) gene. Similar to the observation in fish treated with 2,4 DNT,
the expression of TF was primarily decreased by these compounds
(File S1). Hemoglobin expression in liver tissue was weakly
increased by 2,4DNT, and interestingly it was reduced by 2,6DNT
at 24 h and elevated at 48 h, and was largely reduced by 2ADNT,
4ADNT and TNT. Transferrin carries iron, which is a critical
cofactor of hemoglobin. Oxygen is a substrate of hemoglobin.
2,4DNT can influence oxygen transport by oxidizing hemoglobin
ferrous iron to its ferric state [2]. Hence, oxygen transport gene
deregulation can induce hematological disorder including eryth-
rocytosis.
DNA response activates P53 and other cell death signaling
which ultimately leads to inflammation and other cell death
related diseases. AHR signaling also affects cell death by regulating
P53 signaling and controlling cell cycle gene expression. Two
pathways, AHR and NRF2, belonging to xenobiotic pathway are
primarily responsible for protecting against the toxicity induced by
the compounds. Activation of downstream phase I and phase II
enzymes in these two pathways contribute to detoxification of
xenobiotics leading to cell survival. Another critical commonly
regulated pathway is LPS/IL-1 mediated inhibition of RXR
function pathway. PPARs such as PPARa and PPARg are
involved in this pathway and regulate downstream molecules
contributing to lipid metabolism which is an important significant
common function term down-regulated by all the compounds, as
well as fatty acid metabolism that is a commonly regulated
pathway. The reduction of lipid metabolism by the compounds
could result in endocrine system disorders, reproductive and
hepatic system diseases. LPS/IL-1 mediated pathway is certainly
connected with interleukins and cytokines mediated signaling
which play a role in defense and immune response, which was a
common functional term more heavily down-regulated by TNT
and 4ADNT. Inhibition of immune function by the compounds
could lead to inflammation related diseases. The production of
ROS can also activate NF-kB that connects to ILs and cytokine
signaling. The P53 pathway could also connect with hypoxia
signaling and play a pivotal role in erythrocytosis (File S1). We
found that dinitrotoluene compounds, 2,4DNT, 2,6DNT and
TNT had stronger toxic effects than amino- dinitrotoluene
compounds 2ADNT and 4ADNT. There are some specific
pathways such as nucleotide excision repair pathway that were
only significantly regulated by 2,4DNT and 2,6DNT which could
explain why these two chemicals induce heavier adverse effects.
Immune response related antigen presentation pathway was only
evidently affected by TNT, and there are also more chemokine
ligands that were repressed by TNT. From this, it appears that the
immune system is more of a target for TNT than the other 4
nitrotoluenes.
We also found that liver toxicity could be a secondary effect of
primary hematological toxicities caused by these compounds. We
found hypoxia signaling could be an important pathway affected
by the compounds.
Conclusions
The present study is the first in vivo toxicogenomics study to
investigate the gene transcriptional responses of these munitions
compounds in mammals. We found that 2,4DNT, 2,6DNT and
TNT had stronger toxic effects than 2ADNT and 4ADNT.
Xenobiotic metabolic process was commonly activated by the
compounds and lipid metabolism and immune response were
commonly repressed by the compounds. Several pathways such as
NRF2-mediated oxidative stress response, aryl hydrocarbon
receptor signaling, LPS/IL-1 mediated inhibition of RXR
function, xenobiotic metabolism signaling and metabolism of
xenobiotics by cytochrome P450 were commonly regulated by the
chemicals.
Our results indicate that an integrative systems biology
approach along with physiological findings is an efficient approach
to gain insight into both individual and common mechanisms of
action of the nitrotoluenes in a mammalian system. Concepts
presented in this study can be utilized by others in their research to
understand how a toxicant produces its toxicity.
Materials and Methods
Chemicals
2ADNT (99.9%) and 4ADNT (99.9%) were obtained from SRI
International (Menlo Park, CA). TNT (99.9%) was obtained from
Eastman Chemical Company (Kingsport, TN). 2,4DNT (97%)
and 2,6DNT (98%) were obtained from Sigma-Aldrich (St. Louis,
MO).
Animals and Treatment
Female Sprague-Dawley rats (175–225 grams) were from the in-
house breeding colony (College of Pharmacy, University of
Louisiana at Monroe [ULM] and treated in accordance with the
Guide for Use and Care of Animals [63]. Breeders were from Harlan-
Sprague Dawley in Madison, WI. Housing consisted of a 12 h
light/dark cycle with ad libitum access to tap water and rodent
chow (Harlan/Teklad 7012, Madison, WI). Rats were housed
individually in polycarbonate cages on hardwood bedding (Sani-
chips, Harlan/Tekland, Madison, WI) one week prior to
treatment. Food was withdrawn the night before treatments,
which were administered by gavage between 8 and 10 AM. Study
protocols were preapproved by the Institutional Animal Care and
Use Committee of the University of Louisiana at Monroe (Animal
Welfare Assurance Number A3641-01).
Groups of rats were weighed and randomly assigned to
treatment. Treatments were vehicle (5% v/v DMSO in corn
oil), TNT (4.8, 48, 96, 192, and 384 mg/kg), 4ADNT (4.7, 47, 94,
187, and 374 mg/kg), 2ADNT (4.4, 44, 87, 174, 348 mg/kg),
2,4DNT (5, 50, 99, 198 and 398 mg/kg), and 2,6DNT (5.0, 25,
50, 99, 199, 398 mg/kg). Rats were observed continuously for the
first hour after dosing, hourly for 8 h and daily thereafter.
Moribund rats were euthanized with CO2. All animals died when
dosed with the 2,6DNT high dose (398 mg/kg). At 24 or 48 hours
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sternum was bisected to expose the heart. Blood was collected by
cardiac puncture of the left ventricle into EDTA-containing
Vacutainer tubes (Becton, Dickinson and Co., Franklin Lakes, NJ)
for hematological assessment. Serum was derived from blood
drained from the heart after nicking the ventricles. Livers were
excised and weighed. A 2 mm slice from the medial lobe was fixed
overnight in neutral buffered formalin, then 70% ethanol. A
portion of the liver was removed and placed in RNA Later
(Ambion) following manufacturer’s instruction and later used for
genomic analyses. Remaining liver was flash frozen in liquid N2
and stored at 270uC for lipidomic and analytical chemistry
analyses.
Analytical Chemistry
Upon sacrifice, a portion of liver was flash frozen with liquid
nitrogen then transferred to 280uC. Samples were thawed and
weighed in bead beater tubes (MP Bio, Solon, OH). Next, 500 mL
of high performance liquid chromatography (HPLC)–grade
acetonitrile (.99.93%) (Sigma-Aldrich, St. Louis, MO, USA)
was added to each bead beater tube before being homogenized
using a FastPrepH-24 Instrument (MP Bio, Solon, OH, USA).
After lysing, samples were centrifuged at 16,500 g in a
microcentrifuge to pellet debris. Each supernatant was then
diluted at a ratio of 1:1 with organic free reagent water. Each
diluted extract was then added into a 200 mL glass insert placed in
a 1.5 mL amber vial (Agilent Technologies, Santa Clara, CA,
USA). Samples were analyzed by HPLC using methods modified
from Johnson et al. [64]. Any concentration ,0.200 mg/kg was
considered an estimated value because it was below the lowest
calibration standard. Nitrotoluene standards were analyzed before
during and after sample analysis with 90–110% recovery to ensure
accuracy.
Toxicological Assessments
Histopathological assessment of livers were performed on
sections (5 mm) cut from tissues embedded in paraffin and stained
with hematoxylin and eosin (H&E) using routine procedures [65].
Hematological endpoints were determined by a clinical laboratory
at a local hospital with a CELL-DYN Sapphire System (Abbott
Laboratories, Abbott Park, IL) [66]. Neutrophils, eosinophils and
basophils were summed and reported as granulocytes. Reticulo-
cytes in peripheral blood were vitally stained with new methylene
blue according to manufacturer’s instructions (Procedure No. R
4132, Sigma-Aldrich, St. Louis, MO). Wedge preparations of
stained blood were prepared and slides coded. Reticulocytes were
determined as percentage of 2000 red blood cells counted per
animal.
Serum was analyzed for a panel of metabolic parameters by the
hospital clinical laboratory with an Abbott Architect Ci 8200.
Absolute values for albumin of vehicle-treated rats were low
relative to published normal values [67], which were most likely
due to use of the bromocresol purple binding method with the
instrument calibrated for human albumin. Non-human albumin
Figure 11. An integrated network model to explain the molecular mechanisms of hepatoxicity induced by the compounds.
Environmental chemicals, gene functional terms, pathway cross talks, gene networks, and physiological endpoints were integrated to form a network
at the system level to account for the molecular mechanisms of hepatoxicity mediated by these compounds. Red and green highlighted functional
terms, genes, and pathways were generally up-regulated and down-regulated respectively by these compounds.
doi:10.1371/journal.pone.0014662.g011
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the serum transaminases were approximately twice published
normal values probably due to interference with the colorimetric
assay since serum samples collected from the nicked heart
exhibited some hemolysis as evidenced by a pink color. Hemolysis
was not of such an extent however to affect MCHC. Contami-
nation with enzyme from nicked tissue may also have contributed
to these values. However, these were not expected to affect
detection of treatment related differences because all trials
included concurrent vehicle-treated control groups.
Statistical Analyses
Clinical endpoints were analyzed for homogeneity of variance
with Levene’s test and no heteroscedasticity was observed. Data
were thus analyzed with ANOVA; post-hoc comparisons of
treatment means against concurrent vehicle control were done
with Dunnett’s test. A square root transformation with 3/8
continuity factor was performed on reticulocyte percent data
before analysis. Treatment mean differences from control with
p,0.05 were considered significant.
Microarray experimental design
Changes in gene expression were tested using Agilent
commercial whole rat genome microarrays (4644K). Experiments
were designed for both purposes of temporal and dose response
analysis. For temporal analysis, only two time points for each
compound were used, 24 h and 48 h. For dose response analysis,
four doses plus a vehicle control were employed for each
compound at each time point. A separate control was used for
different compounds even at the same time point. The dose
selection was based on the LD 50 data for each compound. Four
biological replicates of this design were conducted, each using
different animals, and four biological replicates were applied,
which resulted in a total of 200 microarrays.
Total RNA extraction
Total RNA was extracted from about 30mg of liver tissue.
Tissues were homogenized in the lysis buffer with FAST Prep-24
from MP before using RNeasy kits (Qiagen). Total RNA
concentrations were measured using NanoDropH ND-1000
Spectrophotometer (NanoDrop technologies, Wilmington, DE,
USA). The integrity and quality of total RNA was checked on an
Agilent 2100 Bioanalyzer (Palo Alto, CA). The gel-like images
generated by the Bioanalyzer show that total RNAs have two
bands, represent 18S and 26S RNA of mammalian RNA.
Nuclease-free water (Ambion) was used to elute total RNA.
Microarray hybridization
Rat whole genome oligo arrays in the format of 4X44K were
purchased from Agilent Technologies. Sample cRNA synthesis,
labeling, hybridization and microarray processing were performed
according to manufacturer’s protocol ‘‘One-Color Microarray-
Based Gene Expression Analysis’’ (version 1.0). The labeling
reactions were performed using the Agilent Low RNA Input
Linear Amplification Kit in the presence of cyanine 3-CTP. The
labeled cRNA from each labeling reaction was hybridized to
individual arrays at 65uC for 17 h using Agilent’s Gene Expression
Hybridization Kit. After washing, the arrays were scanned using a
GenePix 4200AL scanner (Molecular Device Inc.). The Feature
extraction software (V. 9.5.1) from Agilent was used to
automatically find and place microarray grids, reject outlier pixels,
accurately determine feature intensities and ratios, flag outlier
pixels, and calculate statistical confidences.
Microarray data analysis
Microarray data analyses were processed with GeneSpring version
7.0 and 10.0. The sample quality control was based on the Pearson
correlationofasamplewithothersamplesinthewholeexperiment.If
the average Pearson correlation with other samples was less than
80%, the sample was excluded for further analysis. If the scanned
intensity was less than 5.0 for a probe, it was transformed to 5. Only
one liver sample, TNT at 4.8 mg/ml for 24 h, did not pass the
criteria and was excluded. A perchip (within) array normalization was
performed using 50 percentile values of all the probe values in the
array. Per gene (between) array normalization was also applied using
the median value of a gene across all samples in the experiment.
Probe features were first filtered using flags. A ‘‘present’’ or ‘‘absent’’
flag was defined using the Agilent Feature Extraction 9.5.1 software.
Only a probe that had present flags in at least 50% samples of all the
arrays was kept for further analyses. Data were subsequentlylog (base
2) transformed for statistical analyses. Microarray data has been
deposited in the GEO database (GSE19628).
To extract only significantly regulated genes, a One-Way
ANOVA was performed across 4 doses and a matched control
sample for one compound at a time at either 24 h or 48 h.
Benjamini and Hochberg False Discovery (BHF) Rate with a FDR
[69] wasapplied andonlythetranscriptswithFDR-adjustedPvalue
,=0.05 were considered significant differences. Meanwhile, a
Tukey post-hoc test was conducted to compare the 5 sample groups
including comparing the control group with any one of treatment
group at a certain dose within a One-Way ANOVA test.
To compare the overall gene expression profiles induced by the
5 compounds with various doses and different times, the
microarray data were first normalized by the median value of all
the transcripts per chip. Subsequently each transcript data of all
the samples at a time point (24 h or 48 h) for a compound was
normalized by the mean value of the transcript of the time
matched control samples at the same time point for the same
compound. To obtain the comparison of whole genome level
expression profiles, we used a total of 22,676 flag filtered
transcripts and 40 average conditions to perform a two-way
hierarchical clustering to build a condition tree since that data
were normalized based on relative control samples, control
conditions were excluded in the tree construction. Each dose per
time point for one compound was a unique condition, so a total of
40 average unique conditions were in the tree.
Gene functional analysis and network construction
Significantly regulated probes were employed for one way
hierarchical clustering (only cluster genes) or two-way hierarchical
clustering (clustering both genes and samples) using GeneSpring
7.0 and/or 10 (Agilent Technologies, Foster City, CA, USA). A
Pearson correlation with average linkage was applied for the
clustering. Gene functional categories were classified according to
Gene Ontology (GO) [70] reference using The Database for
Annotation, Visualization and Integrated Discovery (DAVID)
[71,72] and Gofetch [73] tools. A Gene Ontology functional term
enrichment p value less than 0.05 was considered significant.
Pathway analysis was performed using the Ingenuity canonical
pathways analysis tool. Similar to GO analysis, a pathway with an
enrichment p value less than 0.05 was considered to be a
significantly regulated pathway (Ingenuity Systems, Inc., Redwood
City, CA). Gene networks were constructed based on the
Ingenuity knowledge base. A score was assigned to a network
according to the fit of the original set of significant genes. This
score reflects the negative logarithm of the p value that indicates
the likelihood of the focus genes in a network being found together
due to random chance [74].
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Two-stage RT-QPCR were performed, 1000 ng of total RNA
were first reverse transcribed into cDNA in a 20-ml reaction
containing 250 ng random primers and SuperScript
TM III reverse
transcriptase (Invitrogen) following the manufacture’s instruction.
The synthesized cDNA was diluted to10 ng/ml as cDNA template.
QPCR was performed on an Applied Biosystems Incorporated
(ABI, Foster City, CA) Sequence Detector 7900. Each 20-ml
reaction was run in duplicate and contained 6 ml (10 ng/ml) of
synthesized cDNA templates and 3 ul of nuclease-free water along
with 1 ul of TaqMan gene specific assay and 10 ul of 2X TaqMan
universal PCR Master Mix (ABI). Cycling parameters were 95uC
for 15 min to activate the DNA polymerase, then 40 cycles of
95uC for 15 s and 60uC for 1 min.
ESI-MS/MS lipid profiling
Lipids were extracted as described [75]. Briefly, homogenized
liver tissues were added with 2.5 ml of chloroform/methanol/
distilled water (1:1:0.5, v/v), and two 0.5-ml chloroform
extractions. Combined organic phases were washed with 0.5 ml
of KCl (1 m, 16) and with 0.5 ml of dH20( 2 6) and dried with N2
gas. Samples were resuspended in 1 ml of chloroform for the
subsequent analysis. An automated electrospray ionization-tandem
mass spectrometry approach was used for lipidomics study, and
data acquisition and analysis were carried out as described
previously [19,76] with minor modifications. Precise amounts of
internal standards, obtained and quantified as previously described
[19,20], were added in the following quantities (with some small
variation in amounts in different batches of internal standards):
0.60 nmol di12:0-PC, 0.60 nmol di24:1-PC, 0.60 nmol 13:0-
lysoPC, 0.60 nmol 19:0-lysoPC, 0.30 nmol di12:0-PE, 0.30 nmol
di23:0-PE, 0.30 nmol 14:0-lysoPE, 0.30 nmol 18:0-lysoPE,
0.30 nmol 14:0-lysoPG, 0.30 nmol 18:0-lysoPG, 0.30 nmol
di14:0-PA, 0.30 nmol di20:0(phytanoyl)-PA, 0.20 nmol di14:0-
PS, 0.20 nmol di20:0(phytanoyl)-PS, 0.23 nmol 16:0-18:0-PI,
0.16 nmol di18:0-PI, 2.5 nmol 13:0 cholesteryl ester (CE), and
2.5 nmol 23:0 CE. The sample and internal standard mixture was
combined with solvents, such that the ratio of chloroform/
methanol/300 mM ammonium acetate in water was 300/665/35,
and the final volume was 1.2 ml. This mixture for the mass spec
was centrifuged for 15 min to pellet particulates before presenting
to the autosampler. Unfractionated lipid extracts were introduced
by continuous infusion into the ESI source on a triple quadrupole
MS/MS (API 4000, Applied Biosystems, Foster City, CA).
Samples were introduced using an autosampler (LC Mini PAL,
CTC Analytics AG, Zwingen, Switzerland) fitted with the required
injection loop for the acquisition time and presented to the ESI
needle at 30 ml/min. Sequential precursor and neutral loss scans of
the extracts produce a series of spectra with each spectrum
revealing a set of lipid species containing a common head group
fragment. Lipid species were detected with the following scans:
PC, SM, and lysoPC, [M+H]
+ ions in positive ion mode with
Precursor of 184.1 (Pre 184.1); PE and lysoPE, [M+H]
+ ions in
positive ion mode with Neutral Loss of 141.0 (NL 141.0); PI,
[M+NH4]
+ in positive ion mode with NL 277.0; PS, [M+NH4]
+ in
positive ion mode with NL 185.0; PA, [M+NH4]
+ in positive ion
mode with NL 115.0; CE, [M+NH4]
+ in positive ion mode with
Pre 369.3. SM was determined from the same mass spectrum as
PC (precursors of m/z 184 in positive mode) [23–24] and by
comparison with PC internal standards using a molar response
factor for SM (in comparison with PC) determined experimentally
to be 0.39. The collision gas pressure was set at 2 (arbitrary units).
The collision energies, with nitrogen in the collision cell, were
+28 V for PE, +40 V for PC (and SM), +25 V for PI, PS and PA,
and declustering potentials were +100 V for all lipids except CE,
for which the declustering potential was +225 V. Entrance
potentials were +15 V for PE, +14 V for PC (and SM), PI, PA,
and PS, and+10 V for CE. Exit potential were +11 V for PE,
+14 V for PC (and SM), PI, PA, PS, and +10 V for CE. The mass
analyzers were adjusted to a resolution of 0.7 u full width at half
height. For each spectrum, 9 to 150 continuum scans were
averaged in multiple channel analyzer (MCA) mode. The source
temperature (heated nebulizer) was 100uC, the interface heater
was on, +5.5 kV or 24.5 kV were applied to the electrospray
capillary, the curtain gas was set at 20 (arbitrary units), and the two
ion source gases were set at 45 (arbitrary units).
Lipid profile data analysis and statistics
The background of each spectrum was subtracted, the data
were smoothed, and peak areas integrated using a custom script
and Applied Biosystems Analyst software (Foster City, CA, USA).
The lipids in each class were quantified in comparison to the two
internal standards of that class. The first and typically every 11
th
set of mass spectra were acquired on the internal standard mixture
only. Peaks corresponding to the target lipids in these spectra were
identified and molar amounts calculated in comparison to the
internal standards on the same lipid class. To correct for chemical
or instrumental noise in the samples, the molar amount of each
lipid metabolite detected in the ‘‘internal standards only’’ spectra
was subtracted from the molar amount of each metabolite
calculated in each set of sample spectra. Finally, the data were
corrected for the fraction of the sample analyzed and normalized
to the sample ‘‘dry weights’’ to produce data in the units nmol/
mg. To compare the different lipids species between groups, data
was first filtered based on processed signal in which more than
70% of samples have at least 0.002 nmol/mg for any given lipid
species. Otherwise a lipid species was filtered out. Statistic analyses
were conducted by One-Way ANOVA across all doses including
vehicle controls for a compound. The false discovery rate less than
0.05 after Benjamine-Hochberg correction was taken as the cut
off level for significance. A Tukey based post hoc test was applied
to identify differentiated lipid species by comparing different
groups.
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